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ABSTRACT

Roebel, John L. M.S. Anatomy, Department of Neuroscience, Cell Biology and
Physiology, Wright State University, 2006. Developmental Expression of CalciumBinding Proteins in the AVCN and MNTB of Normal Hearing and Congenitally Deaf
Mice.

This experiment analyzes synaptic differences in the central auditory pathway
between normal hearing and congenitally deaf (dn/dn) mice, and provides valuable
insight into central changes that correspond with human congenital deafness.
Specifically, this experiment analyzes developmental expression of the Calcium (Ca2+)binding proteins Calretinin (CR), Calbindin D-28k (CB) and Parvalbumin (PV) in large
excitatory synapses in the anteroventral cochlear nucleus (AVCN) and the medial nucleus
of the trapezoid body (MNTB) of normal and dn/dn mice. Immunofluorescence imaging
with primary antibodies detecting CR, CB or PV was used to analyze the expression of
each at 9 days, 13 days, 20 days, 30 days and 49 days postnatal in normal and dn/dn
mice. Results indicated that Ca2+-binding expression was similar at each location in
normal and dn/dn mice at 9 days postnatal, prior to opening of the ear canal and the onset
of hearing (which occurs around 11 days postnatal) . In normal mice, patterns of Ca2+binding protein expression changed progressively after the onset of hearing. In dn/dn
mice (which completely lack auditory nerve activity), however, patterns of expression did
not change after the onset of hearing, suggesting that patterns of Ca2+-binding protein
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expression change during development in normal mice in response to evoked auditory
nerve activity, and that patterns of Ca2+-binding protein expression do not change during
development in dn/dn mice due to lack of evoked auditory nerve activity. As a result,
Ca2+ buffering is impaired in synapses located in the AVCN and MNTB of dn/dn mice.
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I. INTRODUCTION

This thesis provides insight into the development of synaptic pathways in the
mammalian central nervous system. The aspect of synaptic transmission examined is the
developmental expression and localization of the Calcium-binding proteins Calretinin
(CR), Calbindin D-28k (CB), and Parvalbumin (PV) in synapses located in the central
auditory pathways of normal hearing and congenitally deaf mutant (dn/dn) mice. These
synapses are the endbulb of Held synapse in the anteroventral cochlear nucleus (AVCN),
and the calyx of Held synapse in the medial nucleus of the trapezoid body (MNTB). By
comparing developmental expression of these proteins in normal and congenitally deaf
mice, one can gain appreciation for the role that spontaneous and/or evoked auditory
nerve activity may play in the normal (or abnormal) development of central auditory
pathways in general, and in particular, the central auditory pathways in congenitally deaf
mammals.
The first hypothesis is that CR, CB and PV expression in the AVCN and MNTB
will vary throughout development in normal hearing mice. The expression of each
individual Ca2+-binding protein will change during development, and, in addition, the
patterns of expression of CR, CB and PV will vary with respect to each other. The
results will either validate and expand on, or stand in contrast to, the results obtained by
Felmy and Schneggenburger (2004) on developmental expression of CR, CB and PV in
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the MNTB of normal hearing rats and mice. The next hypothesis is that CR, CB and PV
will display altered expression patterns during development in the AVCN and MNTB of
dn/dn mice. Specifically, there will be differences in Ca2+-binding protein expression in
the AVCN of normal and dn/dn mice. This would support a hypothesis proposed by
Oleskevich and Walmsley (2002), who believed that the enhanced synaptic transmission
they observed in the endbulb of Held synapse in dn/dn mice may result from impaired
Ca2+ buffering in the presynaptic terminal. In addition, there will be topographic
gradients of Ca2+-binding protein expression in the MNTB of normal hearing mice, and
these gradients will be altered or even absent in dn/dn mice. These topographic gradients
(or lack thereof) of Ca2+-binding protein expression may correspond with the established
topographic gradients of current and channel expression that underlie the tonotopic
organization (or lack thereof) of the MNTB of normal hearing (or dn/dn) mice.
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II. SPECIFIC AIMS

The first specific aim was to determine the developmental expression of the
Calcium-binding proteins CR, CB, and PV in the endbulb of Held synapse in the AVCN
and the calyx of Held synapse in the MNTB of the normal hearing mouse. It was
important to determine how the expression of each individual protein varied at given
time-points, and to compare the pattern and location of developmental expression of the
individual proteins with each other. This aim allowed research by Felmy and
Schneggenburger (2004) to be tested and expanded on (see Introduction).
The second specific aim was to examine the developmental expression of CR,
CB, and PV in the AVCN and MNTB of congenitally deaf dn/dn mice. Again, it was
important to determine how expression of each individual Ca2+-binding protein varied
throughout development, and to also compare the pattern and location of expression of
each of these proteins with each other throughout development.
These specific aims allowed comparison of the developmental expression of CR,
CB, and PV in the AVCN and MNTB in normal hearing mice with that in dn/dn mice.
Any significant differences observed would serve as evidence that spontaneous and/or
acoustically evoked auditory nerve activity plays a critical role in the normal pattern of
Ca2+-binding protein expression in the AVCN and MNTB. These aims allowed the
hypothesis proposed by Oleskevich and Walmsley (2002) to be tested (see Introduction),
and provided insight into the role that the developmental expression of these Ca2+-
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binding proteins may play in the creation of tonotopic maps in the AVCN and MNTB
(see Introduction).
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III. BACKGROUND & SIGNIFICANCE

Overview of the Auditory Pathway

The central circuitry in the auditory pathway (Fig. 1) is specialized for sound
localization, using specialized synaptic structures for precise processing of binaural cues
(Walmsley et al. 2006). Neurons in the superior olivary complex, which includes the
medial superior olive (MSO) and lateral superior olive (LSO) nuclei, detect minute
differences in the intensity level (in the LSO) and arrival time (in the MSO) of sound in
each ear. The main synaptic specializations that are necessary for the accuracy and
precision of these cues are giant calyceal terminals in direct contact with the postsynaptic
cell bodies in the pathway. These large presynaptic specializations ensure rapid, highfidelity transmission of the auditory signals (Oleskevich, Youssoufian & Walmsley
2004).
Sound is detected by hair cells in the cochlea, which synapse with spiral ganglion
cells through ribbon synapses. Importantly, these ribbon synapses continually release
neurotransmitter even in the absence of sound stimulation, which results in spontaneous
activity in the auditory nerve fibers (Liberman 1991; see Leao et al. 2006; Walmsley et
al. 2006). This spontaneous activity is present in the auditory nerve even before the
opening of the ear canal and the onset of hearing, which in normal mice is around 12 days
postnatal (Friauf & Lohmann 1999; Rubel & Fritzsch 2002). The central projections of
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Figure 1. The auditory pathway in mammals
This is a simplified schematic diagram showing the cochlear apparatus in the inner ear
and the central projections of spiral ganglion cells, the auditory nerve fibers (AN), which
form giant calyceal type excitatory synapses, the endbulbs of Held, on bushy cells in the
anteroventral cochlear nucleus (AVCN). Spherical bushy cells in the AVCN make
ipsilateral contacts with cells in the lateral superior olive (LSO) and bilateral contacts
(not illustrated) with cells in the medial superior olive (MSO). Globular bushy cells give
rise to axons that form giant calyceal type excitatory synapses, the calyces of Held, with
principal cell somata in the contralateral medial nucleus of the trapezoid body (MNTB).
The principal cells in the MNTB, in turn, give rise to inhibitory axons which project to
the ipsilateral MSO and ipsilateral LSO. Inhibitory glycinergic neurons and synapses are
shown in red, while excitatory glutamatergic neurons and synapses are shown in black.
(Reprinted, with permission, from Walmsley et al. 2006)
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these spiral ganglion cells form the primary auditory nerve fibers which project to the
cochlear nucleus in the brainstem (Liberman 1991; see Walmsley et al. 2006).
The cochlear nucleus is divided into two separate nuclei: the dorsal cochlear
nucleus (DCN) and the anteroventral cochlear nucleus (AVCN). Spherical and globular
bushy cells in the AVCN receive glutamatergic excitatory calyceal-type terminals (Fig. 2)
called endbulbs of Held from the auditory nerve fibers (Oleskevich, Youssoufian &
Walmsley 2004). The spherical bushy cells give excitatory glutamatergic projections
bilaterally to each MSO and ipsilaterally to the LSO. The globular bushy cells give
excitatory glutamatergic projections to the principal cells in the contralateral medial
nucleus of the trapezoid body (MNTB), which terminate in another calyceal-type
terminal (Fig. 2) called the calyx of Held. The MNTB, in turn, gives inhibitory
glycinergic axons to both the ipsilateral MSO and the ipsilateral LSO (Spangler, Warr &
Henkel 1985; Adams & Mugnaini 1990; see Smith, Owens & Forsythe 2000). Thus, the
calyx of Held is viewed as a sign-inverting relay synapse, which converts excitatory
glutamatergic input into inhibitory glycinergic output to the MSO and LSO (Smith, Joris
& Yin 1998; Futai et al. 2001; Paolini et al. 2001; see Oleskevich, Youssoufian &
Walmsley 2004). In addition, there are also various smaller inhibitory synaptic contacts
made with the AVCN and MNTB neurons, which are also important in sound localization
(Leao et al. 2004b; see Walmsley et al. 2006).
The excitatory synapses in the AVCN between the endbulbs of Held and the
bushy cells, and in the MNTB between the calyx of Held and the principal cells, will be
the areas of interest in this experiment. Although the surface area of the calyx of Held is
greater than the endbulb of Held, the two calyceal-type terminals share morphological
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Figure 2. A calyceal-type terminal
This is a schematic depicting an example of a calyceal-type terminal, like those found at
the Endbulb of Held synapse in the AVCN and the Calyx of Held synapse in the MNTB.
(Reprinted, with permission, from Walmsley, Alvarez & Fyffe 1998)
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and physiological features (Neises, Mattox & Gulley 1982; Ryugo, Wu & Pongstaporn
1996; Ryugo et al. 1997; Smith, Joris & Yin 1998; Rowland, Irby & Spirou 2000; Nicol
& Walmsley 2002; Sätzler et al. 2002; Taschenberger et al. 2002; Lee, Cahill & Ryugo
2003; see Oleskevich, Youssoufian & Walmsley 2004). The calyx of Held has been
described as a cup-like structure with finger-like stalks, and it covers about 40% of the
principal cell surface area. A single principal cell is contacted by only one calyx of Held
(Sätzler et al. 2002). Although many bushy cells in the AVCN receive more than one
endbulb of Held (Joris et al. 1994; Nicol & Walmsley 2002), these endbulbs also develop
into finger like structures that cover 40-60% of the bushy cell soma (Ryugo & Fekete
1982; Kuwabara, DiCaprio & Zook 1991; Kandler & Friauf 1993; Smith, Joris & Yin
1998; Sätzler et al. 2002; Taschenberger et al. 2002; see Oleskevich, Youssoufian &
Walmsley 2004). Both endbulbs and calyces of Held contain hundreds of active zones
with clusters of spherical vesicles (Neises, Mattox & Gulley 1982; Ryugo, Wu &
Pongstaporn 1996; Ryugo et al. 1997; Smith, Joris & Yin 1998; Rowland, Irby & Spirou
2000; Nicol & Walmsley 2002; Sätzler et al. 2002; Taschenberger et al. 2002; Lee, Cahill
& Ryugo 2003; see Oleskevich, Youssoufian & Walmsley 2004). Similar changes also
occur at both synapses physiologically, as during development postsynaptic
glutamatergic NMDA receptors are replaced by AMPA receptors (Bellingham, Lim &
Walmsley 1998; Chuhma & Ohmori 1998; Taschenberger & von Gersdorff 2000; Futai et
al. 2001; Joshi & Wang 2002; see Oleskevich, Youssoufian & Walmsley 2004). The
AMPA receptors ensure responses that are among the fastest and largest in the central
nervous system, which allow presynaptic action potentials to generate postsynaptic
responses with very few failures and at very high frequencies (up to 800 Hz) (Wu &
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Kelly 1993; Taschenberger & von Gersdorff 2000; Oleskevich & Walmsley 2002;
Schneggenburger, Sakaba & Neher 2002; see Oleskevich, Youssoufian & Walmsley
2004). Thus, the shared morphological and physiological characteristics of the endbulb
of Held and the calyx of Held play a significant role in ensuring high-fidelity
transmission of auditory information in the central auditory pathway. In addition, the
large size of these synapses, and the fact that the synaptic contacts are made directly with
the cell somata, have made them an ideal target for research on central nervous synapses
(Leao et al. 2004b).

Tonotopic Organization in the Auditory Pathway

There exists a tonotopic organization of cells within the auditory pathway (Friauf
& Lohmann 1999; McAlpine, Jiang & Palmer 2001; Rubel & Fritzsch 2002; Mauk &
Buonomano 2004; see Leao et al. 2006). This tonotopic organization begins in the
cochlea itself, with the hair cells that respond to high sound frequencies in the basal
region of the cochlea, and the hair cells that respond best to low frequencies in the apical
region of the cochlea. This arrangement is continued into the brainstem nuclei of the
auditory pathway (Walmsley et al. 2006). Leao et al. (2006) reported that in the MNTB
of normal hearing mice, cells that respond best to high frequency stimulation are located
medially within the nucleus, whereas cells that respond best to low frequency stimulation
are located more laterally (Fig. 3). They also showed that there are distinct medio-lateral
gradients of voltage-dependent currents and channels types which underlie this tonotopic
organization. For example, they found that in normal mice Kv1.1 channels and their low
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Figure 3. Tonotopic organization of the MNTB in normal and dn/dn mice
Schematics at the top of the figure represent the medio-lateral tonotopic organization of
the MNTB. Schematic at left illustrates that in normal mice, medially-located principal
cells respond best to high frequency stimulation, and laterally-located principal cells
respond best to low frequency stimulation. Below this schematic, gradients of channel
expression that underlie the tonotopic organization of the MNTB in normal mice are
illustrated. Kv3.1 and HC4 channels are preferentially located in medial principal cells,
while Kv1.1 channels are preferentially located in lateral principal cells. Schematic at
right illustrates that in dn/dn mice, no tonotopic organization of cells is observed. Below
this schematic, the lack of gradients of channel expression in the MNTB of dn/dn mice is
illustrated. (Reprinted, with permission, from Walmsley et al. 2006)
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threshold potassium currents are preferentially located in the more lateral MNTB cells,
while Kv3.1 channels with their high threshold potassium currents and HCN4 channels
with their hyperpolarization-activated cation currents are preferentially located in the
more medial cells (Fig. 3). They proposed that these gradients of membrane and firing
properties in the normal mouse MNTB provide a source of time delays, and are thus
important in the localization of sound (Leao et al. 2006).

Congenital Deafness and the Auditory Pathway

In order to study the effects of auditory dysfunction on the central auditory
circuitry, congenitally deaf mutant mice (dn/dn) can be used (Bock, Frank & Steel 1982;
Keats & Berlin 1999; Oleskevich, Youssoufian & Walmsley 2004; Leao et al. 2004a; b;
see Leao et al. 2006). The dn/dn mouse is a naturally occurring strain with a recessive
mutation of Tmc1 (transmembrane cochlear-expressed gene 1) which results in
dysfunctional hair cells in the cochlear apparatus (Leao et al. 2004a). This mutation
results in hair cell dysfunction from birth, with no evidence for spontaneous or
acoustically evoked auditory nerve activity (Bock, Frank & Steel 1982; Keats & Berlin
1999; Oleskevich, Youssoufian & Walmsley 2004; Leao et al. 2004a; b; see Leao et al.
2006). By comparing properties of the central auditory pathways in dn/dn mice and
normal mice, researchers have been able to gain valuable insight into congenital deafness
and the changes that occur with it centrally (Walmsley et al. 2006).
Resent research has shown that the endbulb of Held synapse between auditory
nerve fibers and bushy cells in the AVCN has larger amplitude eEPSCs (evoked
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excitatory postsynaptic currents) in dn/dn mice compared to CBA mice, due to greater
presynaptic release probability, without a change in quantal size (Oleskevich &
Walmsley 2002). This result suggests a homeostatic mechanism of altering synaptic
strength, as the excitatory release from this neuron is being increased in response to a
decrease in firing rate of that neuron in an effort to keep average firing rate near a desired
level (Walmsley et al. 2006). In addition, the endbulb synapse of dn/dn mice showed
greater tetanic depression and frequency of delayed aEPSCs (asynchronous excitatory
postsynaptic currents) (Oleskevich & Walmsley 2002).
Research by Ryugo et al. (1996; 1997; 1998) on endbulb structure in the AVCN
during development of normal and deaf white cats suggests a correlation between amount
of auditory activity and endbulb morphology. They found that in normal cats (with
normal developmental auditory nerve fiber activity), there are smaller and more
numerous synaptic specializations than in deaf white cats (with altered developmental
auditory nerve activity) (Ryugo, Wu & Pongstaporn 1996; Ryugo et al. 1997; Ryugo et
al. 1998; see Walmsley et al. 2006). Walmsley et al. (2006) suggest that these results
support a theory that during normal development, spontaneous auditory nerve activity
causes endbulbs to grow and become specialized, perhaps by a mechanism involving the
splitting into many smaller specializations. Postsynaptically, however, bushy cells in the
AVCN show no difference in the membrane properties between normal and dn/dn mice,
even though the bushy cells in dn/dn mice have lost their excitatory input (Walmsley et
al. 2006).
The excitatory calyx of Held synapse in the MNTB of dn/dn mice, on the other
hand, showed no change in any of the measured properties of evoked synaptic
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transmission and only small changes in spontaneous transmission (Oleskevich,
Youssoufian & Walmsley 2004; Youssoufian, Oleskevich & Walmsley 2005; see
Walmsley et al. 2006). Inhibitory input to the principal cells in the MNTB, however,
shows significant changes between dn/dn and normal mice, as glycinergic mIPSCs
(miniature inhibitory postsynaptic currents) are significantly different in amplitude,
duration, and frequency (Leao et al. 2004b). The principal cells in the MNTB also show
altered membrane properties between normal and dn/dn mice. In dn/dn mice, smaller
low threshold potassium currents in the principal cells results in an increase in their
excitability (Dodson, Barker & Forsythe 2002; Leao et al. 2004a; see Walmsley et al.
2006), and there is also an increase in hyperpolarization activated currents and in highthreshold potassium currents (Leao et al. 2004a; Leao et al. 2005; see Walmsley et al.
2006). Additionally, numerous changes in channel expression have been found in the
MNTB neurons of normal and dn/dn mice. Research by Leao et al. (2005; 2006), has
found in the MNTB of normal mice there are gradients of low-threshold potassium
currents, high-potassium currents, and hyperpolarization-activated cation currents. These
currents correspond with gradients of Kv1.1, Kv3.1, and HCN4 channel expression,
respectively (Fig. 3). In the MNTB of dn/dn mice, however, they found that gradients
did not exist for any of these currents or their corresponding channels (Fig. 3), which
serves as evidence that the developmental formation of the tonotopic map in the mouse
MNTB is related to spontaneous auditory nerve activity (Leao et al. 2005; 2006).
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Role of Calcium in Synaptic Transmission and Calcium-binding Proteins

When a presynaptic action potential reaches a synaptic terminal, it causes voltagedependent calcium channels to open, and calcium ions rush into the presynaptic terminal
due to a large concentration gradient. The increase in intracellular Ca2+ concentration
triggers fusion of neurotransmitter-containing vesicles with the membrane, and
neurotransmitter is released into the synaptic cleft (Katz & Miledi 1965; 1967; 1968;
1970; see Meinrenken, Borst & Sakmann 2002; Felmy, Neher & Schneggenburger 2003).
The key to this process is the neuronal maintenance of extremely low intracellular Ca2+
concentration through Ca2+ extrusion systems (Garcia & Strehler 1999; Kip et al. 2006).
Na+/Ca2+ exchangers and a Ca2+ ATPase (PMCA) in the plasma membrane force Ca2+ out
of the cell (Penniston 1983; Carafoli 1987; Strehler 1990; Miller 1991; see Garcia &
Strehler 1999; Carafoli et al. 2001), and Ca2+ pumps in the endo(sarco)plasmic reticulum
(SERCA) and transporters in mitochondrial membranes sequester Ca2+ in the
endo(sarco)plasmic reticulum and mitochondrial matrices, respectively (Carafoli et al.
2001).
Another important mechanism to maintain the low neuronal cytosolic Ca2+
concentration is found in the actions of Ca2+-binding proteins. The Ca2+-binding proteins
Calretinin (CR), Calbindin D-28k (CB), and Parvalbumin (PV) are found in many
neurons of the central nervous system (Celio 1990; Arai et al. 1991; Resibois & Rogers
1992; see Felmy & Schneggenburger 2004), and more specifically, in the brainstem
auditory nuclei (Arai et al. 1991; Caicedo et al. 1996; Lohmann & Friauf 1996; see
Felmy & Schneggenburger 2004). When present in presynaptic terminals, these Ca2+-
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binding proteins reversibly bind Ca2+ ions and thus modulate transmitter release and
Ca2+-dependent forms of short-term plasticity (Felmy & Schneggenburger 2004). CR
and CB exhibit rapid Ca2+-binding kinetics (Nägerl et al. 2000; see Felmy &
Schneggenburger 2004), and have been shown to reduce peak intracellular Ca2+
concentration by binding incoming Ca2+ ions before they reach the Ca2+ sensor for vesicle
fusion (Edmonds et al. 2000; see Felmy & Schneggenburger 2004). Thus, CR and CB
can decrease transmitter release probability during basal synaptic transmission (Felmy &
Schneggenburger 2004). PV, on the other hand, exhibits slow Ca2+-binding kinetics
(Lee, Schwaller & Neher 2000; see Felmy & Schneggenburger 2004), in which the
delayed Ca2+ binding will accelerate the decay of residual Ca2+ ions (Atluri & Regehr
1996; Lee, Schwaller & Neher 2000; see Felmy & Schneggenburger 2004), and results in
suppression of the amount of transmitter release facilitation (Calliard et al. 2000;
Vreugdenhil et al. 2003; see Felmy & Schneggenburger 2004).
Very few projects have examined the subcellular localization and developmental
changes in the expression of Ca2+-binding proteins in the AVCN and MNTB. Felmy &
Schneggenburger (2004) did examine developmental expression of CR, CB, and PV in
the MNTB of normal hearing rats and mice. Their results indicated that CR is expressed
in some (not all) presynaptic calyces of Held, but not in the postsynaptic principal cells.
They also reported that the number of CR-positive calyces and the density of their
staining increased from 6 days to 31 days postnatal, and that CR-positive calyces in mice
were preferentially located in the lateral portion of the MNTB. They found that CB was
expressed in all postsynaptic principal cell somata, but not in the presynaptic calyces of
Held. It had been previously reported that PV was present in the postsynaptic principal
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cells in the MNTB (Caicedo et al. 1996; Lohmann & Friauf 1996). Felmy and
Schneggenburger (2004) verified that PV was present in the somata of the principal cells,
but in addition they discovered that PV was present in the presynaptic calyces of Held
and their axons. Again, PV staining in the calyces and principal cell somata increased
with development. Taken together, they concluded that up-regulation of CR and PV in
the calyces of Held leads to increased presynaptic Ca2+ buffering strength during
development of normal rats and mice, but that the expression of CR is not uniform in all
calyces of Held (Felmy & Schneggenburger 2004).
To date, there have been no studies analyzing differential expression of Ca2+binding proteins in the MNTB and AVCN between normal and congenitally deaf mice.
Oleskevich & Walmsley (2002), however, found enhanced synaptic strength in the
endbulb of Held synapse in the AVCN of dn/dn mice (aged 11-16 days postnatal) when
compared with normal mice. Their results were based on the finding that transmitter
release probability at this synapse was greater in dn/dn mice. They theorized that
auditory nerve activity in normal hearing mice may act to depress release probability,
thus decreasing synaptic depression and improving high-fidelity transmission. In
addition, they found that administration of the membrane permeable calcium buffer
EGTA-AM diminished all observed differences between deaf and normal mice. As a
result, they suggested impaired calcium buffering in the endbulb terminals of deaf mice
may be responsible for the synaptic differences found between the deaf and normal mice
(Oleskevich & Walmsley 2002). We will, therefore, examine Ca2+ buffering in the
AVCN of normal and dn/dn mice.
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IV. METHODS

Immunohistochemistry

Normal hearing CBA and congenitally deaf mutant (dn/dn) mice from five
different developmental time points were used. The normal hearing CBA mice served as
the wild-type mice in these experiments. The time points used were: 9 days, 13 days, 20
days, 30 days, and 49 days postnatal. The 9 and 13 days postnatal time points were
chosen to represent points immediately before, and immediately after, opening of the ear
canal in both dn/dn and normal mice, which is around 11 days postnatal (Oleskevich &
Walmsley, 2002). The time points 20 and 30 days postnatal represented ages in which
the mice were advancing in development. The 49 day postnatal time point was chosen to
represent developmentally mature mice.
All mice were anaesthetized intraperitoneally with Nembutal (50 mg/ml) at 100
mg/kg body weight and perfused via the left ventricle with cold vascular rinse, (0.01 M
phosphate buffer with 137 mM NaCl, 3.4 mM KCl and 6 mM NaHCO3) followed by
fixative (4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4) for 8-12 minutes.
Following perfusion, brains were removed and post-fixed (4% paraformaldehyde in 0.1
M phosphate buffer, pH 7.4) for one hour. Following post-fixation, the brains were
transferred into 15% Sucrose (in 0.1 M Phosphate Buffer) solution kept at 4°C until ready
for sectioning. Before sectioning, the brainstem/cerebellum was isolated and the rest of
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the brain was discarded. A Microm HM 505E cryostat (Carl Zeiss, Inc., Thornwood,
NY) was used for sectioning. Tissue was submerged in Cryoprotectant Solution (500 ml
0.1 M Phosphate Buffer pH 7.2, 300 g Sucrose, 10 g Polyvinylpyrrolidone, 300 ml
Ethylene glycol, ~200 ml double distilled H20) for 5 minutes, OCT (Tissue-Tek #4583)
for 10 minutes, and then frozen in OCT on a stage in the cryostat at -25°C for 30+
minutes. Transverse sections (10 µm thick) of the brainstem were obtained at the levels
of MNTB and AVCN (Fig. 1) and mounted directly onto slides. After washing with 0.01
M Phosphate-Buffered Saline with 0.2% Triton X-100 (PBS-T), the sections were
incubated in Normal Horse Serum (1:10 in 0.01 M PBS-T) for one hour. After removing
the Normal Horse Serum, the sections were incubated overnight at 4°C in a 0.01 M PBST diluted solution containing the following primary antibodies: mouse anti-Calretinin
(Zymed, San Francisco, CA; 1:500 dilution), mouse anti-Calbindin D-28k (Swant,
Bellinzona, Switzerland; 1:1000 dilution), and mouse anti-Parvalbumin (Chemicon,
Temecula, CA; 1:2000 dilution). Some slides were double-labeled with guinea pig antiVesicular Glutamate Transporter 1 (VGLUT1) (Chemicon, Temecula, CA; 1:1000) in
order to visualize the glutamatergic presynaptic terminals (Fig. 4-5). The sections were
then washed again with PBS-T, and incubated for three hours in Cy-3-conjugated donkey
anti-mouse IgG (1:50 dilution; Jackson, West Grove, PA) or FITC-conjugated donkey
anti-guinea pig IgG (1:50 dilution; Jackson, West Grove, PA) secondary antibodies in
dark conditions (which were maintained for the duration of the experiments). The
sections were then washed with 0.01 M Phosphate-Buffered Saline (PBS). Slides that had
been single labeled were incubated with green fluorescent Nissl stain (1:100; Molecular
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Figure 4. VGLUT1 expression in the AVCN
VGLUT1 is expressed in presynaptic endbulb of Held terminals (arrows) in the AVCN.
Fluorescence image taken at 40X magnification.

medial

lateral
Figure 5. VGLUT1 expression in the MNTB
VGLUT1 is expressed in presynaptic calyx of Held terminals (arrows) in the MNTB.
Confocal image obtained with a 20X dry objective. Dashed line indicates area of MNTB.
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Probes, Eugene, OR) for 5 minutes in order to visualize postsynaptic cell somata (Fig. 67). These slides were washed again with 0.01 M PBS. All slides were cover-slipped
with fluorescence mounting medium (Vectashield, Vector, Burlingame, CA).

Specificity of Antibodies

Mouse anti-Calretinin monoclonal antibody (Zymed, San Francisco, CA) is a
mouse IgG that reacts with Calretinin, a protein with a Molecular Weight (M.W.) of 29
kD. Specificity was proven through immunoblotting followed by two-dimensional gel
analysis. Endogenous expression was shown through microscopy which is standard
protocol for Zymed (personal communication). Mouse anti-Parvalbumin monoclonal
antibody (Chemicon, Temecula, CA) is a mouse IgG that has been shown to react with
Parvalbumin in human, rat, bovine, porcine, feline, rabbit, canine, frog, fish and goat
neural and muscular tissue. By immunoblot it recognizes a M.W. protein of 12 kD. The
antibody is directed against an epitope at the first Ca2+-binding site and specifically stains
the Ca2+-bound form of Parvalbumin. Mouse anti-Calbindin D-28k monoclonal antibody
(Swant, Bellinzona, Switzerland) is a mouse IgG that reacts with Calbindin D-28k from
human, monkey, rabbit, rat, mouse and chicken tissues. It does not react with other
known Ca2+-binding proteins, as it specifically stains the 45CA-binding spot of Calbindin
D-28k (MW 28`000, IEP 4.8) in a two-dimensional gel. In radioimmunoassay it detects
Calbindin D-28k with a sensitivity of 10 ng/assay and an affinity of 1.6 x 1012 L/M.
Guinea Pig anti-Vesicular Glutamate Transporter 1 (VGLUT1) polyclonal antibody
(Chemicon, Temecula, CA) reacts with VGLUT1 protein in nerve fibers and terminals
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Figure 6. AVCN – green fluorescent Nissl staining
Fluorescence image at 20X magnification showing green fluorescent Nissl staining in
postsynaptic bushy cell somata (arrows) within the AVCN.

medial

lateral
Figure 7. MNTB – green fluorescent Nissl staining
Fluorescence image at 20X magnification showing green fluorescent Nissl staining in
postsynaptic principal cell somata (arrows) within the MNTB. Dashed line indicates area
of MNTB.
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(Fig. 4-5). Preabsorption of the VGLUT1 antiserum with immunogen peptide eliminates
all immunostaining, thus confirming its specificity. Cy-3-conjugated donkey anti-mouse
IgG secondary antibody (Jackson, West Grove, PA) reacts with the heavy chains on
mouse IgG and with the light chains common to most mouse immunoglobulins, based on
immunoelectrophoresis. No antibody was detected against non-immunoglobulin serum
proteins. It has been tested by ELISA and/or solid-phase adsorbed to ensure minimal
cross-reaction with bovine, chicken, goat, guinea pig, Syrian hamster, horse, human,
rabbit, and sheep serum proteins. FITC-conjugated donkey anti-guinea pig IgG
secondary antibody (Jackson, West Grove, PA) reacts with the heavy chains on guinea
pig IgG and with the light chains common to most guinea pig immunoglobulins. No
antibody was detected against non-immunoglobulin serum proteins. It has been tested by
ELISA and/or solid-phase adsorbed to ensure minimal cross-reaction with bovine,
chicken, guinea pig, Syrian hamster, horse, human, mouse, rabbit, rat, and sheep serum
proteins. Green fluorescent Nissl stain (Molecular Probes, Eugene, OR) binds to Nissl
substance, or rough endoplasmic reticulum, within the soma of a neuron (Fig. 6-7).
Specifically, it binds to ribosomal RNA on the surface of endoplasmic reticulum, which
is found in abundance in neuronal somata due to their large need for protein synthesis.
The stain is essentially nonfluorescent, except when bound to DNA or RNA.

Imaging & Data Analysis

Epi-fluorescence images were collected at 20X and 40X magnifications using an
Episcopic-Fluorescence Scope (model optiphot-2, Nikon, Mellville, NY) and a Spot RT
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Camera and Software v3.0 (Diagnostic Instruments, Inc., Sterling Height, MI). Confocal
images were obtained using a laser scanning confocal microscope (Olympus Fluoview)
with 20X or 60X dry objectives, digitally magnified 2-3X at 1024x1024 pixel resolution.
Images of Ca2+-binding protein expression in the AVCN were taken from the middle (in
respect to both the medial-lateral axis and the dorsal-ventral axis) of the nucleus. Images
of Ca2+-binding protein expression in the MNTB captured the entire nucleus. In order to
analyze expression of CR, CB, and PV in the AVCN and MNTB, all images of a
respective Ca2+-binding protein were taken with the same exact exposure settings for all
ages in both normal and dn/dn mice. Images were then compared side by side.
When analyzing expression of CR, CB, and PV in the AVCN and MNTB, it was
useful to observe the pattern of expression of each of these proteins in the cerebellum. In
the cerebellum, any Ca2+-binding protein expression should not be affected by the
presence or absence of auditory nerve activity. Thus, the pattern of Ca2+-binding protein
expression in the cerebellum served as a negative control, and was used to ensure that the
staining conditions in the AVCN or MNTB were consistent from animal to animal. In
addition, a control experiment, in which the primary antibodies were omitted, was
conducted to ensure that the secondary antibodies were only binding to the desired
primary antibodies. The results of this experiment showed that the secondary antibodies
were not binding to any other antigens.
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V. RESULTS

AVCN

Calretinin (CR)

In the AVCN, CR was expressed in presynaptic nerve fibers and endbulb of Held
terminals, but not in postsynaptic bushy cell somata (Fig. 8). This pattern of expression
was confirmed by analyzing sections which were double stained for CR (CY3) and green
fluorescent Nissl stain or VGLUT1 (FITC), which stained the postsynaptic bushy cell
somata or presynaptic endbulbs of Held, respectively. In these sections, there was clearly
no co-localization of the CR and Nissl stains, thus indicating that CR was not expressed
in bushy cell somata (Fig. 9). Co-localization was observed in the CR and VGLUT1
stains, confirming the presence of CR in the endbulbs of Held (not shown).
The first line to be analyzed was normal hearing mice. At 9 days postnatal in the
normal hearing mouse, CR was expressed in many nerve fibers and a small number of
endbulbs of Held (compared to the number observed later in development) (Fig. 10).
From 9 days postnatal to 13 days postnatal, the pattern of CR expression began to
change. At 13 days postnatal, CR appeared to be expressed in fewer nerve fibers and in
more endbulbs of Held than at 9 days postnatal (Fig. 11). This pattern of CR being
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Figure 8. Calretinin expression in the AVCN
CR, shown in red, is localized in nerve fibers and presynaptic endbulbs of Held (arrows),
but not in postsynaptic bushy cell somata. Fluorescence image taken at 20X
magnification.

Figure 9. Expression of Calretinin and green fluorescent Nissl in the AVCN
CR, shown in red, is expressed in the endbulbs of Held (arrows), while green fluorescent
Nissl (green) is restricted to the bushy cell somata. No co-localization is observed,
confirming that CR is not present in bushy cell somata. Fluorescence image taken at 20X
magnification.
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Figure 10. Calretinin expression in normal mice at 9 days postnatal in the AVCN
At 9 days postnatal, CR expression in the AVCN of normal mice is relatively diffuse,
with CR expressed in many nerve fibers and a small number of endbulb specializations
(arrows) (compared to that seen later in development). Endbulbs are relatively large in
size (compared to later in development). Fluorescence image obtained at 20X
magnification.

Figure 11. Calretinin expression in normal mice at 13 days postnatal in the AVCN
At 13 days postnatal, CR expression in the AVCN of normal mice is seen in fewer nerve
fibers and in more endbulb specializations (arrows) than in normal mice at 9 days
postnatal. Size of endbulbs appears to have decreased and number of endbulb
specializations appears to have increased. Fluorescence image obtained at 20X
magnification.
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expressed in fewer nerve fibers and more endbulbs of Held continued as development
proceeded. In normal hearing mice at 20 days postnatal, CR was expressed in fewer
nerve fibers and more endbulbs of Held than in the normal mice at 13 days postnatal, and
at 30 days, CR was expressed in fewer nerve fibers and more endbulbs of Held than in
the normal mice at 20 days postnatal (Fig. 12-13). Finally, at 49 days postnatal CR was
expressed in very few nerve fibers and in numerous endbulbs of Held (not shown).
Hence, the overall pattern of the developmental expression in normal hearing mice was
for young mice to express CR in many nerve fibers and few endbulbs of Held, and for
more mature mice to express CR in progressively fewer nerve fibers and progressively
more endbulbs of Held. Interestingly, the size of the endbulb of Held terminals appeared
to decrease throughout development, but the amount of endbulb terminals appeared to
increase (Fig. 14-15).
At 9 days postnatal in dn/dn mice, CR was expressed in many nerve fibers and a
small number of endbulbs of Held (Fig. 16). This pattern was very similar to that which
was observed in the normal hearing mouse at 9 days postnatal. As development
proceeded in dn/dn mice, however, the pattern of CR expression did not appear to change
from that observed in the 9 day mice. Thus, at 13 days, 20 days, 30 days, and even 49
days postnatal in dn/dn mice, CR still appeared to be expressed in many nerve fibers and
a small number of endbulbs of Held (Fig. 17-19; dn/dn 49 day not shown). Also, the
number and size of the endbulb terminals appeared to stay the same as the dn/dn mice
aged from 9 days through 49 days postnatal (Fig. 20-21).
Thus, vast differences were observed in the developmental expression of CR in
the AVCN between normal hearing and congenitally deaf mice. At 9 days
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Figure 12. Calretinin expression in normal mice at 20 days postnatal in the AVCN
At 20 days postnatal, CR expression in the AVCN of normal mice is seen in fewer nerve
fibers and in more endbulbs specializations (arrows) than in normal mice at 13 days
postnatal. Size of endbulbs appears to have decreased and number of endbulb
specializations appears to have increased. Fluorescence image obtained at 40X
magnification.

Figure 13. Calretinin expression in normal mice at 30 days postnatal in the AVCN
At 30 days postnatal, CR expression in the AVCN of normal mice is seen in fewer nerve
fibers and in more endbulb specializations (arrows) than in normal mice at 20 days
postnatal. Size of endbulbs appears to have decreased and number of endbulb
specializations appears to have increased. Fluorescence image obtained at 20X
magnification.
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Figure 14. Calretinin expression in the AVCN of 13 day postnatal normal mice
showing endbulb morphology
The endbulb morphology at 13 days postnatal in normal mice, here visualized by CR
staining, shows relatively large synaptic specializations (arrows). Confocal image taken
with 60X dry objective.

Figure 15. Calretinin expression in the AVCN of 30 day postnatal normal mice
showing altered endbulb morphology
The endbulb morphology (arrows) at 30 days postnatal in normal mice, again visualized
by CR staining, shows a decrease in endbulb size and an increase in number of
specializations as compared to normal mice at 13 days postnatal. Confocal image taken
with 60X dry objective.
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Figure 16. Calretinin expression in dn/dn mice at 9 days postnatal in the AVCN
At 9 days postnatal, CR expression in the AVCN of dn/dn mice is relatively diffuse, with
expression seen in many nerve fibers and a small number of endbulb specializations
(arrow) (compared to that in mature normal mice). Endbulbs are relatively large in size
(compared to that in mature normal mice). Fluorescence image obtained at 20X
magnification.

Figure 17. Calretinin expression in dn/dn mice at 13 days postnatal in the AVCN
At 13 days postnatal, CR expression in the AVCN of dn/dn mice is diffuse, with
expression seen in many nerve fibers and a small number of endbulb specializations
(arrow) (compared to that in mature normal mice). Endbulbs are relatively large in size
(compared to that in mature normal mice). Thus, in respect to CR expression in the
AVCN, dn/dn mice at 13 days postnatal resemble both dn/dn and normal mice at 9 days
postnatal. Fluorescence image obtained at 20X magnification.
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Figure 18. Calretinin expression in dn/dn mice at 20 days postnatal in the AVCN
At 20 days postnatal, CR expression in the AVCN of dn/dn mice is diffuse, with CR seen
in many nerve fibers and a small number of endbulb specializations (arrow) (compared to
that in mature normal mice). Endbulbs are relatively large in size (compared to that in
mature normal mice). Thus, in respect to CR expression in the AVCN, dn/dn mice at 20
days postnatal resemble dn/dn mice at 13 days and both dn/dn and normal mice at 9 days
postnatal. Fluorescence image obtained at 20X magnification.

Figure 19. Calretinin expression in dn/dn mice at 30 days postnatal in the AVCN
At 30 days postnatal, CR expression in the AVCN of dn/dn mice is diffuse, with CR seen
in many nerve fibers and a small number of endbulb specializations (arrow) (compared to
that in mature normal mice). Endbulbs are relatively large in size (compared to that in
mature normal mice). Thus, in respect to CR expression in the AVCN, dn/dn mice at 30
days postnatal resemble dn/dn mice at 9, 13 and 20 days postnatal and normal mice at 9
days postnatal. Fluorescence image obtained at 20X magnification.
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Figure 20. Calretinin expression in the AVCN of 13 day postnatal dn/dn mice
showing endbulb morphology
The endbulb morphology (arrow) at 13 days postnatal in dn/dn mice, here visualized by
CR staining, shows relatively large synaptic specializations, and resembles that in normal
mice at 13 days postnatal. Confocal image taken with 60X dry objective.

Figure 21. Calretinin expression in the AVCN of 30 day postnatal dn/dn mice
showing endbulb morphology
The endbulb morphology (arrows) at 30 days postnatal in dn/dn mice, here visualized by
CR staining, shows relatively large synaptic specializations, and resembles that in both
dn/dn and normal mice at 13 days postnatal. Confocal image taken with 60X dry
objective.
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postnatal in both normal and dn/dn mice, CR was expressed in many nerve fibers and
relatively few endbulb of Held terminals (Fig. 10, Fig. 16). In normal hearing mice,
however, CR expression changed throughout development, as it was expressed in
progressively fewer nerve fibers and progressively more endbulb of Held terminals (Fig.
11-15). In dn/dn mice, on the other hand, there appeared to be no change in CR
expression as development proceeded. The pattern of CR expression in the 9 day
postnatal dn/dn mice was the same as was observed in the 13 day, 20 day, 30 day, and 49
day postnatal dn/dn mice (Fig. 17-21). Because the pattern of CR expression in 9 day
normal and 9 day dn/dn mice was the same, it appeared that CR expression at every age
in dn/dn mice resembled that which was observed in 9 day normal hearing mice. In
addition, the size and number of endbulb of Held terminals were different between
normal and dn/dn mice. In normal mice, endbulb terminals appeared to be large in size
and few in number early in development, and became progressively smaller and more
numerous as development proceeded (Fig. 14-15). In dn/dn mice, endbulb terminals also
appeared to be large in size and few in number early in development. As development
proceeded in the dn/dn mice, however, there was no observed change in the size and
number of endbulb of Held terminals, as mature mice also appeared to have endbulb
terminals that were large in size and few in number (Fig. 20-21).
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Calbindin D-28k (CB)

In the AVCN, Calbindin D-28k was only expressed in postsynaptic bushy cell
somata (Fig. 22). This pattern of CB expression was confirmed by double labeling with
CB (CY3) and green fluorescent Nissl stain or VGLUT1 (FITC). In sections receiving
CB and VGLUT1, no co-localization was observed, confirming that CB was not
expressed in endbulbs of Held (Fig. 23). In sections receiving CB and Nissl, colocalization was observed, confirming the presence of CB in some bushy cell somata
(Fig. 24). Interestingly, CB was not expressed in all bushy cell somata. In fact, CB was
expressed in very few bushy cells (Fig. 23, 24). The amount of CB expression in the
AVCN was far less than was observed for CR and PV. These results applied to both the
normal hearing and congenitally deaf mice.
At 9 days postnatal in normal mice, CB appeared to be expressed weakly in just a
few bushy cell somata (Fig. 25). At 13 days postnatal, CB expression began to change,
as there was an increase in both the number of bushy cell somata expressing CB and in
the intensity of CB staining (Fig. 26). This pattern of CB expression continued as
development proceeded, as the 20 day, 30 day, and 49 day normal mice all showed an
increase in the number of bushy cell somata expressing CB and in the intensity of CB
staining (Fig. 27-28; normal 49 day not shown).
In dn/dn mice, CB expression began as it did in the normal mice, with CB being
expressed weakly in just a few bushy cell somata (Fig. 29). As development proceeded
in dn/dn mice, however, the number of bushy cells expressing CB and the intensity of CB
staining remained the same (Fig. 30-32). Thus, in dn/dn mice, 9 day, 13 day, 20 day, 30
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Figure 22. Calbindin D-28k expression in the AVCN
CB, shown in red, is localized in postsynaptic bushy cell somata (arrow), but not in nerve
fibers or presynaptic endbulbs of Held. Fluorescence image taken at 20X magnification.

*

Figure 23. Expression of Calbindin D-28k and VGLUT1 in the AVCN
CB, shown in red, is localized in some bushy cell somata. * indicates bushy cell not
expressing CB. VGLUT1, shown in green, is localized in endbulbs of Held (arrow). No
co-localization is observed, confirming that CB is not present in the endbulbs of Held.
Fluorescence image taken at 40X magnification.

Figure 24. Expression of Calbindin D-28k and green fluorescent Nissl in the AVCN
CB, shown in red, and green fluorescent Nissl, shown in green, are both localized in
bushy cell somata. Only one bushy cell, at the top left colored yellow (arrow), is positive
for co-localization, yet this confirms the presence of CB in the bushy cell somata.
Fluorescence image taken at 40X magnification.
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Figure 25. Calbindin D-28k expression in normal mice at 9 days postnatal in the
AVCN
At 9 days postnatal in normal mice, CB appeared to be expressed weakly in only a few
postsynaptic bushy cell somata (arrow). Fluorescence image obtained at 20X
magnification.

Figure 26. Calbindin D-28k expression in normal mice at 13 days postnatal in the
AVCN
At 13 days postnatal in normal mice, CB was expressed in more bushy cell somata
(arrow) and stained with greater intensity than in normal mice at 9 days postnatal.
Fluorescence image obtained at 20X magnification.
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Figure 27. Calbindin D-28k expression in normal mice at 20 days postnatal in the
AVCN
At 20 days postnatal in normal mice, CB was expressed in more bushy cell somata
(arrow) and stained with greater intensity than in normal mice at 13 and 9 days postnatal.
Fluorescence image obtained at 20X magnification.

Figure 28. Calbindin D-28k expression in normal mice at 30 days postnatal in the
AVCN
At 30 days postnatal in normal mice, CB was expressed in more bushy cell somata
(arrow) and stained with greater intensity than in normal mice at 20, 13 and 9 days
postnatal. Fluorescence image obtained at 20X magnification.
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Figure 29. Calbindin D-28k expression in dn/dn mice at 9 days postnatal in the
AVCN
At 9 days postnatal in dn/dn mice, CB appeared to be expressed weakly in only a few
postsynaptic bushy cell somata (arrow), and resembled that in normal mice at 9 days
postnatal. Fluorescence image obtained at 20X magnification.

Figure 30. Calbindin D-28k expression in dn/dn mice at 13 days postnatal in the
AVCN
At 13 days postnatal in dn/dn mice, CB again appeared to be expressed weakly in only a
few postsynaptic bushy cell somata (arrow), and resembled that in both dn/dn and normal
mice at 9 days postnatal. Fluorescence image obtained at 20X magnification.
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Figure 31. Calbindin D-28k expression in dn/dn mice at 20 days postnatal in the
AVCN
At 20 days postnatal in dn/dn mice, CB again appeared to be expressed weakly in only a
few postsynaptic bushy cell somata (arrow), and resembled that in dn/dn mice at 9 and 13
days postnatal and normal mice at 9 days postnatal. Fluorescence image obtained at 20X
magnification.

Figure 32. Calbindin D-28k expression in dn/dn mice at 30 days postnatal in the
AVCN
At 30 days postnatal in dn/dn mice, CB again appeared to be expressed weakly in only a
few postsynaptic bushy cell somata (arrow), and resembled that in dn/dn mice at 9, 13
and 20 days postnatal and normal mice at 9 days postnatal. Fluorescence image obtained
at 20X magnification.
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day and 49 day postnatal mice all exhibited similar CB expression, with CB being weakly
expressed in very few bushy cell somata (Fig. 29-32; dn/dn 49 day not shown).
Thus, differences were observed in the developmental expression of CB in the
AVCN of normal hearing and congenitally deaf mice. 9 day postnatal normal and dn/dn
mice both expressed CB weakly in only a few bushy cell somata (Fig. 25, 29). In dn/dn
mice, this pattern of CB expression did not change during development, so CB
expression at all ages in the AVCN of dn/dn mice resembled that which was observed in
9 day postnatal normal hearing mice (Fig. 29-32). Normal hearing mice, however,
exhibited a developmental change in CB expression, as progressively more bushy cell
somata exhibited CB expression, and the intensity of CB staining increased (Fig. 25-28).

Parvalbumin (PV)

In the AVCN, PV was expressed in nerve fibers and both presynaptically, in
endbulbs of Held, and postsynaptically, in the bushy cell somata (Fig. 33). PV appeared
to be expressed in all endbulbs and all bushy cells in the AVCN. These results were
confirmed by utilizing double-labeling experiments with PV (CY3) and green fluorescent
Nissl stain or VGLUT1 (FITC). Sections stained with PV and Nissl showed colocalization, confirming the presence of PV in the postsynaptic bushy cell somata (not
shown). Sections stained with PV and VGLUT1 also showed co-localization, confirming
the presence of PV in the presynaptic endbulbs of Held (not shown).
Normal hearing mice at 9 days postnatal expressed PV presynaptically in nerve
fibers and endbulb of Held terminals, and also postsynaptically in bushy cell somata
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Figure 33. Parvalbumin expression in the AVCN
PV, seen in red, is localized in presynaptic endbulbs of Held (arrow) and in postsynaptic
bushy cell somata (*). Fluorescence image obtained at 40X magnification.
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(not shown). At this stage of development, the intensity of PV staining in the endbulbs of
Held was far greater than the staining intensity in the bushy cell somata. Thus, at 9 days,
PV was expressed at a higher level presynaptically than postsynaptically in normal
hearing mice. As development proceeded, the level of PV expression in the postsynaptic
bushy cells increased progressively (Fig. 34, 35). In 30 day postnatal normal mice, the
strength of PV intensity was so strong postsynaptically that it was not possible to
distinguish PV staining in the bushy cells from that in the endbulbs of Held, mainly
because of the close opposition of the endbulbs with the bushy cell somata (Fig. 36). As
a result, it was not clear what was happening with PV expression in the endbulbs of Held
during development. One possibility was that PV expression in the endbulbs of Held
stayed the same throughout development. Another possibility, however, was that PV
expression in the endbulbs was decreasing throughout development, and was being
masked by the PV expression increase in the bushy cells. A final possibility was that PV
expression did increase in the endbulbs, but that this increase was being masked by the
large increase in PV expression in the bushy cell somata.
At 9 days postnatal in dn/dn mice, PV was also present in the presynaptic nerve
fibers and endbulb of Held terminals and postsynaptically in bushy cell somata (Fig. 37).
At this stage, PV staining was again stronger in the endbulbs of Held than in the bushy
cell somata. As development proceeded in dn/dn mice, no change in PV expression was
observed (Fig. 38-40). All ages of dn/dn mice showed the same pattern of PV expression
that was observed in the 9 day postnatal dn/dn mice, with PV staining stronger in the
presynaptic endbulbs of Held than in the postsynaptic bushy cell somata.
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Figure 34. Parvalbumin expression in normal mice at 13 days postnatal in the
AVCN
At 13 days postnatal in the AVCN, PV staining is slightly stronger in the postsynaptic
bushy cell somata (*) than was seen at 9 days postnatal. PV expression in the endbulbs
of Held (arrows) appears to be about the same in 13 day as in 9 day postnatal normal
mice. Fluorescence image obtained at 20X magnification.
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Figure 35. Parvalbumin expression in normal mice at 20 days postnatal in the
AVCN
At 20 days postnatal in the AVCN, PV staining is slightly stronger in the postsynaptic
bushy cell somata (*) than was seen at 13 days postnatal. PV expression in the endbulbs
of Held appears to be about the same in 20 day as in 13 day and 9 day postnatal normal
mice. Fluorescence image obtained at 20X magnification.
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Figure 36. Parvalbumin expression in normal mice at 30 days postnatal in the
AVCN
At 30 days postnatal in the AVCN, PV staining is stronger in the postsynaptic bushy cell
somata (*) than was seen at 20 days postnatal. PV expression in the endbulbs of Held
appears to be about the same in 30 day as in 20, 13 and 9 day postnatal normal mice.
Fluorescence image obtained at 20X magnification.

45

*

Figure 37. Parvalbumin expression in dn/dn mice at 9 days postnatal in the AVCN
At 9 days postnatal, PV expression in the AVCN of dn/dn mice is seen in presynaptic
endbulbs of Held and in postsynaptic bushy cell somata. At 9 days in dn/dn mice,
staining is stronger in the endbulbs (arrow) than in the bushy cell somata (*), and
resembles that seen in 9 day postnatal normal mice. Fluorescence image obtained at 20X
magnification.
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Figure 38. Parvalbumin expression in dn/dn mice at 13 days postnatal in the AVCN
At 13 days postnatal, PV expression in the AVCN of dn/dn mice is seen in presynaptic
endbulbs of Held and in postsynaptic bushy cell somata. At 13 days in dn/dn mice,
staining is stronger in the endbulbs (arrow) than in the bushy cell somata (*), and
resembles that seen in 9 day postnatal dn/dn mice and 9 day postnatal normal mice.
Fluorescence image obtained at 20X magnification.
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Figure 39. Parvalbumin expression in dn/dn mice at 20 days postnatal in the AVCN
At 20 days postnatal, PV expression in the AVCN of dn/dn mice is seen in presynaptic
endbulbs of Held and in postsynaptic bushy cell somata. At 20 days in dn/dn mice,
staining is stronger in the endbulbs (arrow) than in the bushy cell somata (*), and
resembles that seen in 9 and 13 day postnatal dn/dn mice and 9 day postnatal normal
mice. Fluorescence image obtained at 20X magnification.
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Figure 40. Parvalbumin expression in dn/dn mice at 30 days postnatal in the AVCN
At 30 days postnatal, PV expression in the AVCN of dn/dn mice is seen in presynaptic
endbulbs of Held and in postsynaptic bushy cell somata. At 30 days in dn/dn mice,
staining is stronger in the endbulbs (arrow) than in the bushy cell somata (*), and
resembles that seen in 9, 13 and 20 day postnatal dn/dn mice and 9 day postnatal normal
mice. Fluorescence image obtained at 20X magnification.
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Thus, differences in the developmental expression of PV were observed in the
AVCN of normal hearing and congenitally deaf mice. In both normal and dn/dn mice,
PV expression at 9 days postnatal was far greater in the presynaptic endbulbs of Held
than in the postsynaptic bushy cell somata (Fig. 34, 37). This pattern of PV expression in
dn/dn mice did not change during development, so at all ages PV expression in the
AVCN of dn/dn mice resembles that which was observed in 9 day postnatal normal
hearing mice (Fig. 37-40). In normal hearing mice, however, PV expression did change
during development, as PV staining intensity in the postsynaptic bushy cell somata
increased progressively as development proceeded (Fig. 34-36). Again, it was not clear if
PV expression in the presynaptic endbulbs of Held changed during development or, if it
did, whether that change was an increase or decrease in PV expression.

MNTB

Calretinin (CR)

In the MNTB, Calretinin was observed in nerve fibers and presynaptic calyx of
Held terminals, as well as in postsynaptic principal cell somata (Fig. 41). CR was not
expressed in all calyces of Held, and was also not expressed in all principal cell somata.
In addition, a topographic pattern of CR expression was observed with respect to the
medio-lateral organization of the MNTB (see below). These results were confirmed
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Figure 41. Calretinin expression in the MNTB
A. CR, seen in red, is localized in presynaptic calyces of Held (arrow) and postsynaptic
principal cell somata (*) in the MNTB. Fluorescence image obtained at 20X
magnification. Dashed line indicates area of MNTB. Note, in the lower left corner of the
image, the fibers of the trapezoid body, which carry axons from the contralateral AVCN,
and were used to positively identify the location of the MNTB. B. Image obtained at
40X showing principal cell somata (*) from the medial MNTB expressing CR. C. Image
obtained at 40X showing calyces of Held (arrow) from the lateral MNTB expressing CR.
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using double labeling experiments with CR (CY3) and green fluorescent Nissl stain or
VGLUT1 (FITC). Sections stained with CR and Nissl showed some co-localization,
confirming the presence of CR in some principal cell somata (Fig. 42). Sections stained
with CR and VGLUT1 also showed some co-localization, indicating the presence of CR
in some calyces of Held (Fig. 43).
Normal hearing mice at 9 days postnatal expressed CR mainly in principal cell
somata preferentially located in the medial portion of the MNTB (Fig. 44). At this age,
CR was expressed in very few calyces of Held. CR expression in normal mice began to
change at 13 days postnatal. At this age, CR was still expressed mainly in principal cell
somata medially, but CR also began to be expressed in a few calyces of Held
preferentially located in the lateral MNTB (Fig. 45). At 20 and 30 days postnatal, CR
was expressed in progressively fewer principal cell somata medially, and progressively
more calyces of Held laterally (Fig. 46, 47). By the time normal mice reached 49 days
postnatal, CR was expressed mainly in calyces of Held throughout the MNTB (even
though most were still laterally located), with only an occasional medially-located
principal cell soma expressing CR (not shown). Thus, a topographic gradient of CR
expression was observed in the MNTB. This topographic gradient changed during
development of the normal hearing mice. Early in development, CR was expressed
mainly in principal cell somata in the medial MNTB. As development proceeded, CR
was expressed in progressively fewer principal cell somata medially, and progressively
more calyces of Held laterally. In mature normal hearing mice, CR was expressed in
very few principal cell somata medially, and very many calyces of Held throughout the
MNTB, with most still being located laterally.
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Figure 42. Expression of Calretinin and green fluorescent Nissl in the MNTB
This is a 20X dry objective confocal image showing CR (red) and green fluorescent Nissl
(green) expression in the MNTB. Areas of co-localization appear yellow (*), and
confirm the presence of CR in principal cell somata. Dashed line indicates area of
MNTB.
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Figure 43. Expression of Calretinin and VGLUT1 in the MNTB
This is a 20X dry objective confocal image showing CR (red) and VGLUT1 (green)
expression in the MNTB. Areas of co-localization appear yellow, and confirm the
presence of CR in calyces of Held (arrow) and in principal cell somata (*). Dashed line
indicates area of MNTB.
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Figure 44. Calretinin expression in normal mice at 9 days postnatal in the MNTB
A. Fluorescence image (20X) of 9 day postnatal normal mouse MNTB, showing CR
expression mainly in principal cell somata (*) in the medial MNTB (to the right), and CR
expression in very few calyces of Held. Dashed line indicates area of MNTB. B.
Confocal image (20X dry objective) showing CR (red) and VGLUT1 (green) expression
in the MNTB of a normal mouse at 9 days postnatal. CR is seen mainly in principal cell
somata (*) in the medial MNTB (to the left) and in very few calyces of Held. Areas of
yellow indicate co-localization. Dashed line indicates area of MNTB.
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Figure 45. Calretinin expression in normal mice at 13 days postnatal in the MNTB
Fluorescence image (20X) showing the MNTB of a normal mouse at 13 days postnatal.
CR (red) is still expressed in a few principal cell somata (*) medially (as in normal mice
at 9 days postnatal), but has begun to be expressed in more calyces of Held (arrow)
laterally than in normal mice at 9 days postnatal. Dashed line indicates area of MNTB.
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Figure 46. Calretinin expression in normal mice at 20 days postnatal in the MNTB
CR (red) is still expressed in a few principal cell somata medially (*) (as in normal mice
at 9 and 13 days postnatal), but is expressed in more calyces of Held (arrow) laterally
than in normal mice at 9 and 13 days postnatal. Dashed line indicates area of MNTB. A.
Fluorescence image (20X) B. Confocal image (20X dry objective).
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Figure 47. Calretinin expression in normal mice at 30 days postnatal in the MNTB
At 30 days postnatal in normal mice, CR (red) is expressed in fewer principal cell somata
(*) in the medial MNTB than at 20, 13 and 9 days postnatal in normal mice. CR is also
expressed in far more calyces of Held (arrow) (particularly in the lateral MNTB) at 30
days postnatal than at 20, 13 and 9 days postnatal in normal mice. Dashed line indicates
area of MNTB. A. Fluorescence image (20X). B. Confocal image (20X dry objective).
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Congenitally deaf mice at 9 days postnatal also expressed CR mainly in principal
cell somata preferentially located in the medial portion of the MNTB (Fig. 48). At 9 days
CR was again expressed in very few calyces of Held, and if they did express CR, they
were located laterally. During development, however, dn/dn mice did not exhibit a
change in CR expression. All ages of dn/dn mice expressed CR in principal cell somata
medially, along with an occasional calyx of Held in the lateral MNTB (Fig. 49-51).
Thus, a topographic gradient of CR expression existed in dn/dn mice, but this
topographic gradient did not change during development.
Thus, significant differences were observed in the developmental expression of
CR in the MNTB of normal hearing and congenitally deaf mice. At 9 days postnatal, in
both normal and dn/dn mice, CR was expressed mainly in medially-located principal cell
somata, with very few calyces of Held expressing CR laterally (Fig. 44, 48). The pattern
of CR expression in dn/dn mice did not change during development, so CR expression in
all ages of dn/dn mice resembled that which was observed in 9 day postnatal normal
hearing mice (Fig. 44, 48-51). In normal mice, on the other hand, the pattern of CR
expression changed throughout development. CR was expressed in progressively more
calyces of Held laterally, and progressively fewer principal cell somata medially, as
development proceeded (Fig. 44-47). By 49 days postnatal, normal hearing mice mainly
expressed CR in calyces of Held (throughout the MNTB, but most located laterally), with
only an occasional medially-located principal cell soma expressing CR (not shown). The
topographic pattern of CR expression in dn/dn mice remained the same throughout
development, while the topographic pattern of CR expression in normal hearing mice
changed during development.
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Figure 48. Calretinin expression at 9 days postnatal in dn/dn mice in the MNTB
At 9 days postnatal in dn/dn mice, CR (red) is expressed in principal cell somata (*) in
the medial MNTB, and very few calyces of Held. This pattern in 9 day postnatal dn/dn
mice is very similar to that in 9 day postnatal normal mice. Dashed line indicates area of
MNTB. A. Fluorescence image (20X). B. Confocal image (20X) dry objective.
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Figure 49. Calretinin expression at 13 days postnatal in dn/dn mice in the MNTB
At 13 days postnatal in dn/dn mice, CR (red) is still expressed mainly in principal cell
somata (*) in the medial MNTB, and in very few calyces of Held, a pattern very similar
to that in 9 day postnatal dn/dn and 9 day postnatal normal mice. Dashed line indicates
area of MNTB. A. Fluorescence image (20X). B. Confocal image, double labeled with
VGLUT1 (green), showing both MNTBs (10X dry objective). C. Confocal image,
double labeled with VGLUT1 (20X dry objective).
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Figure 50. Calretinin expression at 20 days postnatal in dn/dn mice in the MNTB
At 20 days postnatal in dn/dn mice, CR is still expressed mainly in principal cell somata
(*) in the medial MNTB, and in very few calyces of Held. This pattern of CR expression
is very similar to that in 9 and 13 day postnatal dn/dn mice and 9 day postnatal normal
mice. Dashed line indicates area of MNTB. A. Fluorescence image (20X). B. Confocal
image (20X dry objective).
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Figure 51. Calretinin expression at 30 days postnatal in dn/dn mice in the MNTB
At 30 days postnatal in dn/dn mice, CR is still expressed mainly in principal cell somata
(*) in the medial MNTB, and in very few calyces of Held (arrow). This pattern of CR
expression is very similar to that in 9, 13 and 20 day postnatal dn/dn mice and 9 day
postnatal normal mice. Dashed line indicates area of MNTB. A. Fluorescence image
(20X). B. Confocal image (20X dry objective).
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Calbindin D-28k (CB)

In the MNTB, Calbindin was observed in some nerve fibers and the postsynaptic
principal cell somata, but not in the presynaptic calyces of Held (Fig. 52). CB appeared
to be present in the somata of all principal cells in the MNTB. These results were
confirmed using double-labeling with CB (CY3) and green fluorescent Nissl stain or
VGLUT1 (FITC), in order to identify areas of co-localization. Sections receiving CB and
Nissl showed co-localization (Fig. 53), confirming the presence of CB in the principal
cell somata. Sections receiving CB and VGLUT1 did not show co-localization (Fig. 54),
confirming that CB was not present in the presynaptic calyces of Held.
Normal hearing mice at 9 days postnatal expressed CB in all of the postsynaptic
principal cell somata. The intensity of CB staining in the principal cells appeared
uniform throughout the medio-lateral extent of the MNTB (Fig. 55). During
development, the pattern of CB expression in normal mice appeared to change. At 13
days postnatal, the intensity of CB staining in principal cell somata located in the lateral
portion of the MNTB appeared to increase slightly (Fig. 56). This gradual increase in CB
staining intensity in the lateral MNTB continued throughout development, as CB
intensity in the lateral MNTB appeared stronger in the 20 and 30 day postnatal normal
mice (Fig. 57, 58). By 49 days postnatal, there appeared to be a distinct medio-lateral
gradient of CB expression in the MNTB of normal mice (not shown). The intensity of
CB staining in the lateral principal cell somata appeared to be significantly stronger than
that in the medial cells. Thus, a topographical gradient of CB expression appeared to
occur during development in normal hearing mice.
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Figure 52. Calbindin D-28k expression in the MNTB
CB, seen in red, is localized in principal cell somata (arrow), not in calyces of Held.
Dashed line indicates area of MNTB. Confocal image taken with 20X dry objective.
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Figure 53. Expression of Calbindin D-28k and green fluorescent Nissl in the MNTB
CB (red) and green fluorescent Nissl (green) are both localized in principal cell somata,
but not in the calyces of Held. Areas of co-localization (arrow) (yellow) confirm the
presence of CB in principal cell somata. Dashed line indicates area of MNTB.
Fluorescence image taken at 20X.
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Figure 54. Expression of Calbindin D-28k and VGLUT1 in the MNTB
Confocal image, taken with the 60X dry objective, showing double labeling of CB (red)
and VGLUT1 (green) in the MNTB. CB is observed only in the principal cell somata (*),
and VGLUT1 is observed only calyces of Held (arrow). Little co-localization was
observed.
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Figure 55. Calbindin D-28k expression at 9 days postnatal in normal mice in the
MNTB
At 9 days postnatal, CB expression in normal mice is observed in all postsynaptic
principal cell somata in the MNTB. Staining intensity appears to be about equal
throughout the entire medio-lateral extent of the MNTB. Dashed line indicates area of
MNTB. Fluorescence image at 20X magnification.
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Figure 56. Calbindin D-28k expression at 13 days postnatal in normal mice in the
MNTB
At 13 days postnatal, CB expression in normal mice is observed in all postsynaptic
principal cell somata in the MNTB. Staining intensity appears to be increasing in cells in
the lateral MNTB, and remaining about equal in cells in the medial MNTB (in
comparison to staining intensity in normal mice at 9 days postnatal). Dashed line
indicates area of MNTB. Fluorescence image at 20X magnification.
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Figure 57. Calbindin D-28k expression at 20 days postnatal in normal mice in the
MNTB
At 20 days postnatal, CB expression in normal mice is observed in all postsynaptic
principal cell somata in the MNTB. Staining intensity appears to be increasing in cells in
the lateral MNTB, and remaining about equal in cells in the medial MNTB (in
comparison to staining intensity in normal mice at 13 days postnatal). Dashed line
indicates area of MNTB. Fluorescence image at 20X magnification.
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Figure 58. Calbindin D-28k expression at 30 days postnatal in normal mice in the
MNTB
At 30 days postnatal, CB expression in normal mice is observed in all postsynaptic
principal cell somata in the MNTB. Staining intensity at this stage is clearly greater in
principal cells in the lateral MNTB than in cells in the medial MNTB. Dashed line
indicates area of MNTB. Fluorescence image at 20X magnification.
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Congenitally deaf mice at 9 days postnatal also expressed CB in all of the
postsynaptic principal cell somata. At this age, the intensity of CB staining in the
principal cells appeared uniform throughout the medio-lateral extent of the MNTB (Fig.
59). During development in dn/dn mice, however, no change appeared to occur in the
pattern of CB expression. Thus, in dn/dn mice at all observed ages (9, 13, 20, 30 and 49
days postnatal) CB staining intensity appeared uniform throughout the medio-lateral
extent of the MNTB (Fig. 59-62; dn/dn 49 day not shown). No topographical gradient of
CB expression in the MNTB appeared to occur during development in congenitally deaf
mice.
Thus, large differences appeared to occur in the developmental expression of CB
in the MNTB of normal hearing and congenitally deaf mice. In both normal and dn/dn
mice at 9 days postnatal, CB expression in principal cell somata appeared uniform
throughout the medio-lateral extent of the MNTB (Fig. 55, 59). No change in the
developmental expression of CB appeared to occur in dn/dn mice, as all subsequent ages
appeared to resemble the pattern of expression in both normal and dn/dn mice at 9 days
postnatal (Fig. 55, 59-62). There was no apparent topographic gradient of CB expression
in the MNTB during development in dn/dn mice. Normal hearing mice, however, did
appear to exhibit a developmental change in CB expression, as CB staining intensity
appeared to increase in the lateral principal cell somata throughout development (Fig. 5558). In the mature normal hearing mice, a distinct topographic gradient of CB expression
in the medio-lateral organization of the MNTB was observed (Fig. 57, 58). Importantly,
all observations of CB staining intensity were obtained only from analyzing fluorescence
images. Detailed optical density analysis, through a DAB staining
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Figure 59. Calbindin D-28k expression at 9 days postnatal in dn/dn mice in the
MNTB
At 9 days postnatal in dn/dn mice, CB staining intensity appears to be about equal
throughout the medio-lateral extent of the MNTB. This pattern is similar to the one
observed in 9 day postnatal normal mice. Dashed line indicates area of MNTB.
Fluorescence image at 20X magnification.
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Figure 60. Calbindin D-28k expression at 13 days postnatal in dn/dn mice in the
MNTB
At 13 days postnatal in dn/dn mice, CB staining intensity appears to be about equal
throughout the medio-lateral extent of the MNTB. This pattern is similar to the one
observed in 9 day postnatal dn/dn and 9 day postnatal normal mice. Dashed line
indicates area of MNTB. Fluorescence image at 20X magnification.
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Figure 61. Calbindin D-28k expression at 20 days postnatal in dn/dn mice in the
MNTB
At 20 days postnatal in dn/dn mice, CB staining intensity appears to be about equal
throughout the medio-lateral extent of the MNTB. This pattern is similar to the one
observed in 9 and 13 day postnatal dn/dn and 9 day postnatal normal mice. Dashed line
indicates area of MNTB. Fluorescence image at 20X magnification.
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Figure 62. Calbindin D-28k expression at 30 days postnatal in dn/dn mice in the
MNTB
At 30 days postnatal in dn/dn mice, CB staining intensity appears to be about equal
throughout the medio-lateral extent of the MNTB. This pattern is similar to the one
observed in 9, 13, and 20 day postnatal dn/dn and 9 day postnatal normal mice. Dashed
line indicates area of MNTB. Fluorescence image at 20X magnification.
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experiment, is needed to quantify and verify these results. Such an experiment is
currently underway.

Parvalbumin (PV)

In the MNTB, Parvalbumin was expressed in nerve fibers and presynaptically in
calyces of Held, as well as postsynaptically in principal cell somata (Fig. 63). PV
appeared to be expressed in all calyces of Held, as well as all principal cell somata, in the
MNTB. These results were confirmed by again utilizing double-labeling experiments
with PV (CY3) and green fluorescent Nissl stain or VGLUT1 (FITC). Sections stained
with PV and Nissl showed co-localization (not shown), confirming the presence of PV in
the principal cell somata. Sections stained with PV and VGLUT1 also showed colocalization (Fig. 64), confirming the presence of PV in the calyces of Held.
Normal hearing mice at 9 days postnatal expressed PV in nerve fibers and
presynaptic calyces of Held, and postsynaptically in principal cell somata (Fig. 65). At
this age, the intensity of PV staining appeared to be far greater in the calyces of Held than
in the principal cell somata. As development proceeded in normal mice, the intensity of
PV staining in the postsynaptic principal cell somata increased progressively (Fig. 6668). By 49 days postnatal, the intensity of PV staining in the principal cells had increased
dramatically (not shown). At this point, it was not possible to distinguish the
postsynaptic principal cell somata from the calyces of Held, as both were in close
opposition and expressing PV. As a result, it was impossible to determine if there were
developmental changes in PV expression in the presynaptic calyces of Held. It is
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Figure 63. Parvalbumin expression in the MNTB
In the MNTB, PV is expressed in both presynaptic calyces of Held and postsynaptic
principal cell somata (*). Fluorescence image taken at 20X magnification.
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Figure 64. Expression of Parvalbumin and VGLUT1 in the MNTB
Confocal image (20X dry objective) showing dual labeling of PV (red) and VGLUT1
(green). Areas of co-localization appear yellow, and indicate that PV is present in the
presynaptic calyces of Held (arrow). PV is also present in the principal cell somata (*).

69

lateral

medial

*

Figure 65. Parvalbumin expression at 9 days postnatal in normal mice in the
MNTB
At 9 days postnatal in normal mice, PV staining intensity is stronger in the presynaptic
calyces of Held (arrow) than in the postsynaptic principal cell somata (*). Dashed line
indicates area of MNTB. Fluorescence image taken at 20X magnification.
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Figure 66. Parvalbumin expression at 13 days postnatal in normal mice in the
MNTB
At 13 days postnatal in normal mice, PV staining intensity is still stronger in the calyces
of Held (arrow), but PV staining intensity in the principal cell somata (*) is beginning to
increase. Dashed line indicates area of MNTB. A. Fluorescence image taken at 20X
magnification. B. Confocal image obtained with 20X dry objective.
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Figure 67. Parvalbumin expression at 20 days postnatal in normal mice in the
MNTB
At 20 days postnatal in normal mice, PV staining intensity is still stronger in calyces of
Held (arrow), but PV staining intensity continues increasing in the principal cell somata
(*). Dashed line indicates area of MNTB. Fluorescence image at 20X magnification.
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Figure 68. Parvalbumin expression at 30 days postnatal in normal mice in the
MNTB
At 30 days postnatal in normal mice, PV staining intensity in most postsynaptic principal
cell somata (*) has increased so that it is difficult to distinguish the postsynaptic element
from the staining in the presynaptic calyces of Held (arrow). Dashed line indicates area
of MNTB. Fluorescence image taken at 20X magnification
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possible that the level of PV expression did not change in the calyces of Held.
Alternatively, PV expression could have increased or decreased, but due to the close
opposition of the pre- and postsynaptic elements which were both expressing PV, this
could not be determined in these experiments. Thus, the large increase in PV staining
intensity in the postsynaptic principal cell somata masked whatever changes (if any) may
have occurred in PV expression in the presynaptic calyces of Held.
At 9 days postnatal in congenitally deaf mice, PV was expressed in nerve fibers
and presynaptic calyces of Held, and postsynaptically in principal cell somata (Fig. 69).
At this stage the intensity of PV staining in the calyces of Held was far greater than in the
principal cell somata. As development proceeded in dn/dn mice, no changes in PV
expression occurred in the MNTB (Fig. 70-71). Thus, dn/dn mice of all ages exhibited
the same pattern of PV expression as was observed in 9 days postnatal dn/dn mice, with
PV staining stronger in the presynaptic calyces of Held than in the postsynaptic principal
cell somata.
Thus, significant differences were observed in the developmental expression of
PV in the MNTB of normal hearing and congenitally deaf mice. At 9 days postnatal in
both normal and dn/dn mice, PV staining was stronger in the presynaptic calyces of Held
than in the postsynaptic principal cell somata (Fig. 65, 69). In dn/dn mice, no
developmental changes in PV expression were observed, resulting in all ages of dn/dn
mice resembling the 9 days postnatal normal hearing and congenitally deaf mice (Fig. 65,
69-71). Normal hearing mice, however, did exhibit developmental changes in PV
expression in the MNTB. As development proceeded, the PV staining intensity in the
postsynaptic principal cell somata increased progressively (Fig. 65-68). It was not clear
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medial

lateral
Figure 69. Parvalbumin expression at 9 days postnatal in dn/dn mice in the MNTB
At 9 days postnatal in dn/dn mice, PV staining intensity is much stronger in the calyces
of Held (arrow) than in the principal cell somata. This pattern closely resembles that
observed in 9 day postnatal normal mice. Fluorescence image taken at 20X
magnification.
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medial

lateral
Figure 70. Parvalbumin expression at 20 days postnatal in dn/dn mice in the MNTB
At 20 days postnatal in dn/dn mice, PV staining intensity is still much stronger in the
calyces of Held (arrow) than in the principal cell somata. This pattern closely resembles
that observed in 9 and 13 day postnatal dn/dn and 9 day postnatal normal mice. Dashed
line indicates area of MNTB. Fluorescence image taken at 20X magnification.

medial
lateral
Figure 71. Parvalbumin expression at 30 days postnatal in dn/dn mice in the MNTB
At 30 days postnatal in dn/dn mice, PV staining intensity is still much stronger in the
calyces of Held (arrow) than in the principal cell somata. This pattern closely resembles
that observed in 9, 13, and 20 day postnatal dn/dn and 9 day postnatal normal mice.
Fluorescence image taken at 20X magnification.
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if the level of PV expression in the presynaptic calyces of Held changed during
development, because the increase in PV staining in the principal cell somata masked any
changes that may have occurred in the calyces of Held due to their close opposition to
one another.
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VI. DISCUSSION

Developmental Expression of Ca2+-binding Proteins in Normal Hearing Mice

In normal hearing mice, patterns of Ca2+-binding protein expression in the
endbulb of Held synapse in the AVCN and in the calyx of Held synapse in the MNTB
appeared to be developmentally regulated (Fig. 72, 73), which validated the first
proposed hypothesis (see Introduction). For each of the Ca2+-binding proteins, a distinct
pattern of expression was present at 9 days postnatal, before opening of the ear canal.
The pattern of expression for each of these proteins was changed at 13 days postnatal,
after opening of the ear canal, and then continued to change as the normal mice
progressed through development thereafter.
In addition, the location and developmental pattern of expression for each
individual protein (Calretinin, Calbindin D-28k, and Parvalbumin) varied with respect to
one another in the AVCN and MNTB of normal mice. CR (Fig. 10-15, 44-47) was
expressed mainly in presynaptic terminals in the AVCN and MNTB, but also in a few
postsynaptic somata in the MNTB of normal mice early in development. CR appeared to
be expressed in all presynaptic terminals in the AVCN, but was not expressed in all
presynaptic terminals in the MNTB. In addition, CR was expressed in a topographic
pattern in the MNTB, and this topographic pattern changed during development. CB
(Fig. 25-28, 55-58) was expressed only in postsynaptic somata in the AVCN and
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Figure 72. Trends in the AVCN
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Development 

Figure 73. Trends in the MNTB
Relative Expression of Calretinin in
Principal Cell Somata in Medial MNTB
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dn/dn

Development 

MNTB. CB was expressed in all postsynaptic somata in the MNTB, but was not
expressed in all of the postsynaptic somata in the AVCN. There was also a topographic
pattern of CB expression in the MNTB during development. PV (Fig. 34-36, 65-68) was
expressed in both presynaptic terminals and postsynaptic somata in the AVCN and
MNTB. It appeared that PV was present in all presynaptic terminals and all postsynaptic
terminals in both the AVCN and MNTB. There was no apparent topographic pattern of
PV expression in the MNTB during development.
The localization and developmental patterns of expression of CR, CB and PV in
the MNTB (in normal mice) had been studied previously by Felmy and Schneggenburger
(2004). They reported that CR was present in many, but not all, presynaptic calyces of
Held, and that the number of CR-positive calyces and the intensity of their staining
increased from 6 to 31 days postnatal. In addition, they reported that CR was expressed
by calyces that were preferentially located in the lateral MNTB. The results of this
experiment (Fig. 44-47) verified all of these findings for CR in the MNTB by Felmy and
Schneggenburger. In addition, however, it was discovered that CR is expressed mainly in
a few postsynaptic principal cells in the medial MNTB of 9 day postnatal normal mice.
As development proceeded, CR began being expressed in more calyces of Held laterally,
and less principal cell somata medially. Thus, a topographic pattern of CR expression in
the MNTB was observed, and this topographic pattern changed during development.
Felmy and Schneggenburger also reported that CB was expressed in all postsynaptic
principal cell somata, but not in presynaptic calyces of Held. The results of this
experiment (Fig. 55-58) verified their finding, but in addition, a topographic pattern of
CB expression was observed. As development proceeded, CB staining intensity in
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principal cells in the lateral MNTB appeared to increase, while the staining intensity in
the medial MNTB appeared to remain the same. Felmy and Schneggenburger reported
that PV was expressed in both presynaptic calyces of Held and postsynaptic principal cell
somata, and that PV staining intensity in both calyces and principal cells increased during
development. This series of experiments (Fig. 65-68) verified that PV is present both
pre- and postsynaptically in the MNTB of normal mice. In addition, PV expression
during development appeared to increase in the postsynaptic principal cells, which agreed
with their results. This experiment, however, could not determine what changes, if any,
had taken place in PV expression in the presynaptic calyces of Held. Any changes that
took place for PV expression in the calyces of Held were masked due to the increase in
PV expression in postsynaptic principal cells and the close opposition of pre- and
postsynaptic elements. Thus, many of the results from Felmy and Schneggenburger
(2004) were validated, but this experiment added some potentially important details to
the patterns of developmental expression and localization of CR, CB and PV in the
MNTB of normal hearing mice (Fig. 73).

Developmental Expression of Ca2+-binding Proteins in Congenitally Deaf Mice

In congenitally deaf mice, developmental regulation of Ca2+-binding protein
expression in the AVCN and MNTB was altered, as specific patterns and changes seen
during development in normal mice were not observed in dn/dn mice (Fig. 72, 73). These
results supported the second proposed hypothesis (see Introduction). For each of the
Ca2+-binding proteins, a distinct pattern of expression was present at 9 days postnatal,
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before opening of the ear canal. The pattern of expression for each of these proteins was
unchanged, however, at 13 days postnatal, after opening of the ear canal, and then
appeared to remain the same as the dn/dn mice progressed through development
thereafter.
The location and developmental pattern of expression of each individual protein
(Calretinin, Calbindin D-28k, and Parvalbumin) did, however, vary with respect to one
another in the AVCN and MNTB in dn/dn mice. CR in dn/dn mice (Fig. 16-21, 48-51)
was expressed in presynaptic endbulbs of Held in the AVCN, and in postsynaptic
principal cell somata in the MNTB. CR appeared to be expressed in all presynaptic
endbulb terminals in AVCN, but in only a few postsynaptic somata in the medial portion
of the MNTB (a topographic gradient). CB (Fig. 29-32, 59-62) was expressed only in
postsynaptic somata in both the AVCN and MNTB of dn/dn mice. CB appeared to be
present in all postsynaptic principal cell somata in the MNTB, but no topographic
gradient was observed at any stage of development. CB was expressed only in
postsynaptic bushy cell somata in the AVCN, but was present in only a few of the bushy
cells. PV (Fig. 37-40, 69-71) was expressed simultaneously in both presynaptic terminals
and postsynaptic somata in the AVCN and MNTB, with the presynaptic elements
staining more intensely throughout the development of dn/dn mice. It appeared that PV
was present in all presynaptic terminals and all postsynaptic terminals in both the AVCN
and MNTB. There was no apparent topographic pattern of PV expression in the MNTB
during development of dn/dn mice.
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Developmental Expression of Ca2+-binding Proteins in Normal vs. dn/dn Mice

The results of this experiment revealed differences between normal hearing and
congenitally deaf mice in the developmental expression of Ca2+-binding proteins in the
AVCN and MNTB (Fig. 72, 73). In both the AVCN and MNTB, normal and dn/dn mice
at 9 days postnatal showed the same pattern of expression for each individual Ca2+binding protein. For example, CR was expressed mainly in postsynaptic principal cell
somata in the medial MNTB at 9 days postnatal in normal and dn/dn mice (Fig. 44, 48),
and CB was expressed in only a few postsynaptic bushy cell somata in the AVCN in both
normal and dn/dn mice at 9 days (Fig. 25, 29). After opening of the ear canal, however,
the pattern of Ca2+-binding protein expression in normal mice began to change, while the
pattern of Ca2+-binding protein expression in dn/dn mice remained the same. These
patterns continued throughout the course of development, so that normal mice at 49 days
postnatal showed much difference in the pattern of Ca2+-binding protein expression as
compared to normal mice at 9 days, and the pattern of Ca2+-binding protein expression in
dn/dn mice at 49 days postnatal closely resembled that in both normal and dn/dn mice at
9 days.
The patterns of expression for each individual Ca2+-binding protein began the
same in normal hearing and congenitally deaf mice at 9 days postnatal, which was prior
to opening of the ear canal and the onset of hearing. The patterns began to change in
normal mice at 13 days postnatal, which was just after opening of the ear canal, and
continued to change throughout the rest of development. The patterns of Ca2+-binding
protein expression in dn/dn mice, however, remained the same even after opening of the
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ear canal. It is tempting, therefore, to suggest that the differences in Ca2+-binding protein
expression during the development of normal hearing and congenitally deaf mice were a
result of differences in auditory nerve activity. Because the patterns of expression were
the same in normal and dn/dn mice at 9 days, it would appear that spontaneous nerve
activity plays little role in expression before opening of the ear canal. If spontaneous
nerve activity was involved, it would likely result in different patterns of Ca2+-binding
protein expression in normal and dn/dn mice at 9 days postnatal. Instead, it would appear
that differences in evoked auditory nerve activity are responsible, because the patterns of
Ca2+-binding protein expression only began to differ after opening of the ear canal, which
corresponds to the onset of hearing. Normal hearing mice, therefore, experience changes
in Ca2+-binding protein expression during development because of evoked auditory nerve
activity, while dn/dn mice, which lack evoked auditory nerve activity, experience no
changes in Ca2+-binding protein expression during development.

Impaired Ca2+ Buffering in the AVCN of dn/dn Mice

Oleskevich & Walmsley (2002) found enhanced synaptic strength in the endbulb
of Held synapse in the AVCN of dn/dn mice (aged 11-16 days postnatal) when compared
with normal mice. Their results were based on the finding that transmitter release
probability at this synapse was greater in dn/dn mice. They theorized that auditory nerve
activity in normal hearing mice may act to depress release probability, thus decreasing
synaptic depression and improving high-fidelity transmission. In addition, they found
that administration of the membrane permeable calcium buffer EGTA-AM diminished all
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observed differences between deaf and normal mice. As a result, they suggested
impaired calcium buffering in the endbulb terminals of deaf mice may be responsible for
the synaptic differences found between the deaf and normal mice (Oleskevich &
Walmsley 2002).
The differences observed in Ca2+-binding protein expression in the AVCN
between normal and dn/dn mice in this experiment (Fig. 72) support the hypothesis
proposed by Oleskevich and Walmsley (2002). CR and PV (Fig. 8-21, 33-40), which
were heavily expressed in the AVCN, appeared to be the main Ca2+-binding proteins
involved in the endbulb of Held synapse, as CB (Fig. 22-32) was only observed in a few
postsynaptic bushy cell somata (at any given age). CR was expressed in presynaptic
endbulb terminals at moderate levels in both normal and dn/dn mice at 9 days postnatal
(Fig. 10, 16). CR expression increased dramatically throughout the rest of development
in normal mice (Fig. 11-15). In dn/dn mice, however, CR expression remained the same
throughout the rest of development (Fig. 17-21), with all subsequent ages resembling the
9 day postnatal dn/dn (and 9 day normal) mice. Thus, the patterns of CR expression
showed that presynaptic Ca2+ buffering progressively increased after opening of the ear
canal in normal mice, but remained the same in dn/dn mice. At 9 days postnatal in both
normal and dn/dn mice, PV was expressed in presynaptic endbulb terminals and
postsynaptic bushy cell somata, with the presynaptic terminals staining much stronger
than the postsynaptic somata (Fig. 34, 37). During development it was unclear if the
expression of PV in the presynaptic terminals had changed in both normal and dn/dn
mice (see Results). In normal mice, PV expression progressively increased in the
postsynaptic bushy cell somata throughout the rest of development (Fig. 34-36). PV
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expression in the bushy cells of dn/dn mice, however, remained the same throughout
development (Fig. 37-40), with all subsequent ages resembling the 9 day postnatal dn/dn
(and normal) mice. Thus, the patterns of PV expression showed that postsynaptic Ca2+
buffering progressively increased after opening of the ear canal in normal mice, but
remained the same in dn/dn mice. Patterns of CB expression also showed a
developmental increase in postsynaptic Ca2+ buffering in normal mice, and absence of
this developmental increase in dn/dn mice (Fig. 25-32). The result showing impaired
Ca2+ buffering in the postsynaptic bushy cells is surprising, because Walmsley et al.
(2006) reported that postsynaptic bushy cells in the AVCN show no difference in the
membrane properties between normal and dn/dn mice, even though the bushy cells in
dn/dn mice have lost their excitatory input.
It is important to note that CR and CB exhibit rapid Ca2+-binding kinetics (Nägerl
et al. 2000; see Felmy & Schneggenburger 2004) and that PV exhibits slow Ca2+-binding
kinetics (Lee, Schwaller & Neher 2000; see Felmy & Schneggenburger 2004). Thus, in
the AVCN of normal mice, there is a developmental increase in a presynaptic Ca2+binding protein that exhibits rapid binding kinetics (CR) and a developmental increase in
a postsynaptic Ca2+-binding protein that exhibits rapid binding kinetics (CB) as well as
one that exhibits slow binding kinetics (PV). CR and CB should act to decrease
transmitter release probability during basal synaptic transmission (Felmy &
Schneggenburger 2004), and PV should suppress the amount of transmitter release
facilitation (Calliard et al. 2000; Vreugdenhil et al. 2003; see Felmy & Schneggenburger
2004). A developmental increase in CR, CB and PV would presumably ensure the
fidelity of synaptic transmission at the endbulb of Held synapse in normal mice. In the
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AVCN of dn/dn mice, however, neither the presynaptic CR nor the postsynaptic CB/PV
increased. The results of this experiment, therefore, support the hypothesis that impaired
calcium buffering in the AVCN of deaf mice may be responsible for the synaptic
differences found between the deaf and normal mice (Oleskevich & Walmsley 2002), and
show that this impaired calcium buffering is present both pre- and postsynaptically, and
involves both rapidly and slowly acting Ca2+-binding proteins.

Altered Endbulb Morphology in the AVCN of Normal Mice

Research by Ryugo et al. (1996; 1997; 1998) on endbulb structure in the AVCN
during development of normal and deaf white cats suggests a correlation between amount
of auditory activity and endbulb morphology. They found that in normal cats (with
normal developmental auditory nerve fiber activity), there are smaller and more
numerous synaptic specializations than in deaf white cats (with altered developmental
auditory nerve activity) (Ryugo, Wu & Pongstaporn 1996; Ryugo et al. 1997; Ryugo et
al. 1998; see Walmsley et al. 2006). Walmsley et al. (2006) suggest that these results
support a theory that during normal development, spontaneous auditory nerve activity
causes endbulbs to grow and become specialized, perhaps by a mechanism involving the
splitting into many smaller specializations. The present experiment appeared to support
this theory, as endbulbs in mature normal mice (Fig. 12-13, 15, 72), which were
visualized by CR staining and VGLUT1 staining, appeared to be smaller and have more
numerous specializations than endbulbs in younger normal mice (Fig. 10-11, 14, 72) and
dn/dn mice at all ages (Fig. 16-21, 72). It can be inferred, therefore, if these observations
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are accurate, that auditory nerve activity in mice causes endbulb morphology to change
during development, with mature endbulbs in normal mice being smaller with more
numerous specializations than endbulbs in younger normal mice and dn/dn mice at all
ages. It is important to note that this experiment did not quantify this result, and that
more detailed analysis of endbulb size and morphology during development in normal
hearing and congenitally deaf mice, perhaps through a detailed confocal microscopic
experiment, needs to be studied.

Topographic Gradients of Ca2+-binding Proteins in the MNTB – Normal vs. dn/dn
Mice

The results of the current experiment indicated that CR and CB were expressed in
topographic patterns in the MNTB during the development of normal hearing mice, and
that these gradients were altered (absent) in congenitally deaf mice (Fig. 73). (The
developmental expression of PV in the MNTB did not appear to involve any topographic
patterns in normal or dn/dn mice.) Furthermore, these topographic gradients (or lack
thereof) of Ca2+-binding expression appeared to correspond with the established
topographic gradients of channel and current expression that underlie the tonotopic
organization (or lack thereof) of the MNTB of normal hearing (or congenitally deaf) mice
(see Background & Significance; Fig. 3).
In both normal and dn/dn mice at 9 days postnatal, CR was expressed mainly in
postsynaptic principal cell somata in the medial part of the MNTB (Fig. 44, 48). This
pattern of CR expression remained consistent throughout development in dn/dn mice
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(Fig. 49-51). During the development of normal mice, however, CR was expressed in
progressively fewer medially-located postsynaptic principal cell somata, and
progressively more laterally-located presynaptic calyces of Held (Fig. 45-47). CR,
therefore, was expressed, in normal mice before opening of the ear canal and dn/dn mice
at all ages, in principal cell somata in the medial MNTB. These cells have been shown to
respond well to high frequency stimulation, and to preferentially express Kv3.1 channels
and their high threshold potassium currents (Leao et al. 2006) (Fig. 3). As development
proceeded following opening of the ear canal in normal mice, CR was expressed in
progressively fewer principal cell somata medially, and in progressively more calyces of
Held in the lateral MNTB. These lateral calyces synapse with cells that have been shown
to respond well to low frequency stimulation, and to preferentially express Kv1.1
channels and their low threshold potassium currents (Leao et al. 2006) (Fig. 3). It can be
inferred, therefore, that during normal development, a greater level of presynaptic Ca2+
buffering is required in the lateral MNTB in order to ensure the fidelity of low frequency
signal transmission. As stated previously, the results of this experiment have indicated
that the topographic pattern of CR expression changes in normal mice in response to
evoked auditory nerve activity. As a result, the need for an increased level of presynaptic
Ca2+ buffering in the lateral MNTB of normal mice is satisfied as CR expression in the
calyces of Held is increased in response to evoked auditory nerve activity. Auditory
nerve activity is absent in dn/dn mice, and as a result, no change in the topographic
gradient of CR expression occurs in the MNTB after opening of the ear canal. Thus, in
dn/dn mice the need for an increased level of presynaptic Ca2+ buffering in the lateral
MNTB is not satisfied. In other words, there is no need for an increased level of
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presynaptic Ca2+ buffering in the lateral MNTB of dn/dn mice because evoked auditory
nerve activity is absent.
In both normal and dn/dn mice at 9 days postnatal, CB was expressed at a
consistent level in all postsynaptic principal cell somata throughout the medio-lateral
extent of the MNTB (Fig. 55, 59). This pattern of CB expression remained consistent
throughout development in dn/dn mice (Fig. 60-62). During the development of normal
mice, however, the level of CB expression increased progressively in laterally-located
postsynaptic principal cell somata (Fig. 56-58). These cells have been shown to respond
well to low frequency stimulation, and to preferentially express Kv1.1 channels and their
low threshold potassium currents (Leao et al. 2006) (Fig. 3). As stated previously, the
results of this experiment have indicated that the topographic pattern of CB expression
changes in normal mice in response to evoked auditory nerve activity. As a result, an
increased level of postsynaptic Ca2+ buffering in the lateral MNTB of normal mice occurs
as CB expression in the principal cell somata is increased in response to evoked auditory
nerve activity. Auditory nerve activity is absent in dn/dn mice, and as a result, no
topographic gradient of CB expression occurs in the MNTB after opening of the ear
canal. Thus, a developmental increase in CB expression does not occur in postsynaptic
principal cell somata in the lateral MNTB of dn/dn mice.
Thus, the levels of expression of two separate Ca2+-binding proteins, CR
presynaptically and CB postsynaptically, are increased during development in normal
mice in the lateral MNTB. The topographic gradients of CR and CB expression that
develop in the MNTB of normal mice appear in the lateral MNTB, which have been
shown to possess cells that respond best to low frequency stimulation (Leao et al. 2006).
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These cells preferentially express Kv1.1 channels and their low frequency potassium
currents (Leao et al. 2006) (Fig. 3), and thus the topographic gradient of CR and CB
expression that occurs in the development of normal mice corresponds to these
topographic gradients of Kv1.1 channels and low frequency potassium currents. In
contrast, lack of evoked auditory activity in dn/dn mice resulted in the absence of
topographic gradients of CR and CB expression in the MNTB during development, and
as such, increased Ca2+ buffering in the lateral MNTB was not achieved. The lack of
topographic gradients of CR and CB expression in dn/dn mice corresponds with the lack
of topographic gradients of channel and current expression, which presumably underlie
that altered tonotopic organization of the MNTB in dn/dn mice (Leao et al. 2005, 2006)
(Fig. 3).

Kinetics of Ca2+-binding Proteins in the MNTB of Normal vs. dn/dn Mice

When analyzing the developmental expression of Ca2+-binding proteins in
relation to tonotopic organization of the MNTB in normal hearing and congenitally deaf
mice, it is important to take into account the binding kinetics of the specific Ca2+-binding
proteins. As a Ca2+-binding protein that exhibits fast binding kinetics (Nägerl et al. 2000;
see Felmy & Schneggenburger 2004), CR should act to decrease transmitter release
probability during basal synaptic transmission (Felmy & Schneggenburger 2004). It
would seem, therefore, that CR would be a Ca2+-binding protein that would be especially
well-suited to ensure the fidelity of high frequency transmission. Such a pattern of CR
expression was not observed, however, in the MNTB of normal mice. Although CR was
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expressed in young normal mice mainly in principal cell somata in the medial MNTB
(Fig. 44), which is the high frequency end of the tonotopic map (Leao et al. 2006) (Fig.
3), increased levels of CR expression in the MNTB of more mature normal mice were
found in calyces of Held in the lateral MNTB (Fig. 45-47), which is the low frequency
end of the tonotopic map (Leao et al. 2006) (Fig. 3). Thus, it appears that in the MNTB,
CR is a Ca2+-binding protein that is expressed in an effort to ensure the fidelity of low
frequency synaptic transmission. Congenitally deaf mice at all ages of development, on
the other hand, retain the pattern of CR expression seen in young normal mice (Fig. 44,
48-51). As a result, CR expression is not shifted to the lateral MNTB, and the fidelity of
low frequency synaptic transmission is not ensured.
As another Ca2+-binding protein that exhibits fast binding kinetics (Nägerl et al.
2000; see Felmy & Schneggenburger 2004), the presynaptic function of CB would be to
decrease transmitter release probability during basal synaptic transmission (Felmy &
Schneggenburger 2004). CB, however, was only observed in the postsynaptic principal
cell somata in the MNTB (Fig. 52-62). The specific postsynaptic function of CB in the
principal cell somata is not known. Presumably, CB would still maintain low cytosolic
Ca2+ levels through fast binding kinetics, but postsynaptically it would not affect
neurotransmitter release.
PV is a Ca2+-binding protein that exhibits slow Ca2+-binding kinetics (Lee,
Schwaller & Neher 2000; see Felmy & Schneggenburger 2004), in which the delayed
Ca2+ binding will accelerate the decay of residual Ca2+ ions (Atluri & Regehr 1996; Lee,
Schwaller & Neher 2000; see Felmy & Schneggenburger 2004), and presynaptically
results in suppression of the amount of transmitter release facilitation (Calliard et al.

92

2000; Vreugdenhil et al. 2003; see Felmy & Schneggenburger 2004). In this experiment,
expression of PV in the MNTB was observed in both the presynaptic calyces of Held and
the postsynaptic principal cell somata (Fig. 63-64), and no topographic gradients of PV
expression were observed in normal or dn/dn mice. In young normal mice, PV
expression in the calyces of Held is far greater than in the principal cell somata (Fig. 65).
This pattern was observed as well in dn/dn mice at all ages of development (Fig. 69-71).
It was unclear if PV expression in the presynaptic calyces changed during normal mice
development (see Results and Discussion above). As a result, no statement can be made
in regard to the role that developmental changes in presynaptic PV expression may play
in synaptic transmission at the calyx of Held synapse. During development of the normal
mice, PV expression increased dramatically in the postsynaptic principal cell somata
(Fig. 66-68). The specific postsynaptic function of PV in the principal cell somata is not
known. Presumably, PV would still maintain low cytosolic Ca2+ levels through slow
binding kinetics, but postsynaptically it would not affect neurotransmitter release. Since
no topographic gradients of PV expression were observed presynaptically or
postsynaptically in the MNTB of normal or dn/dn mice (Fig. 65-71), it appears that PV is
a Ca2+-binding protein that is equally important in the high and low frequency ends of the
tonotopic map in the MTNB.
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VII. CONCLUSIONS

The expression of the Ca2+-binding proteins Calretinin (CR), Calbindin D-28k
(CB) and Parvalbumin (PV) in the Anteroventral Cochlear Nucleus (AVCN) and Medial
Nucleus of the Trapezoid Body (MNTB) of normal hearing mice varies during
development (Fig. 72, 73). The expression of each Ca2+-binding protein is at a certain
level in specific locations in the AVCN and MNTB at 9 days postnatal, before opening of
the ear canal, and begins to change at 13 days postnatal, after opening of the ear canal.
The patterns of Ca2+-binding protein expression in normal mice continue to change from
13 days postnatal through the duration of development. In addition, the pattern of
expression for each individual Ca2+-binding protein in the AVCN and MNTB of normal
mice is unique when compared to the patterns of expression for the other Ca2+-binding
proteins.
In congenitally deaf mice (dn/dn), the patterns of expression for CR, CB and PV
in the AVCN and MNTB do not vary during development (Fig. 72, 73). The expression
of each Ca2+-binding protein is at a certain level in specific locations in the AVCN and
MNTB at 9 days postnatal, before opening of the ear canal, and remains the same in all
ages of dn/dn mice after opening of the ear canal. Thus, the pattern of expression for
each Ca2+-binding protein in the AVCN and MNTB of dn/dn mice remains the same
throughout development. The pattern of expression for each individual Ca2+-binding
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protein in the AVCN and MNTB of dn/dn mice, however, is unique when compared to
the patterns of expression for the other Ca2+-binding proteins.
Differences occur in the developmental expression of CR, CB and PV in the
AVCN and MNTB between normal and dn/dn mice (Fig. 72, 73). These differences
occur as a result of the presence (in normal mice) or absence (in dn/dn mice) of evoked
auditory nerve activity. Expression of each individual Ca2+-binding protein in the AVCN
and MNTB appears to be the same at 9 days postnatal, before opening of the ear canal, in
both normal and dn/dn mice. Expression of each individual Ca2+-binding protein in the
AVCN and MNTB remains the same at all ages of development after opening of the ear
canal in dn/dn mice. In normal mice, however, the pattern of expression for each
individual Ca2+-binding protein in the AVCN and MNTB begins to change at 13 days
postnatal, after opening of the ear canal, and continues to change throughout the duration
of development. Because the patterns of expression for each individual Ca2+-binding
protein is the same before opening of the ear canal, it appears that the presence or
absence of spontaneous auditory nerve activity plays little role in expression patterns
before the onset of hearing. The differences in Ca2+-binding protein expression in the
AVCN and MNTB between normal and dn/dn mice do occur, on the other hand, as a
result of the presence (in normal mice) or absence (in dn/dn mice) of evoked auditory
nerve activity. This is because dn/dn mice, which lack evoked auditory nerve activity,
retain the same patterns of Ca2+-binding protein expression before and after the opening
of the ear canal, and normal mice, which experience evoked auditory nerve activity,
exhibit changed patterns of Ca2+-binding protein expression after opening of the ear
canal.
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This experiment shows that there is impaired Ca2+ buffering in the AVCN of
dn/dn mice (Fig. 72). In normal mice, there is a developmental increase in presynaptic
(CR) Ca2+-binding protein expression in the endbulb of Held terminals, and in
postsynaptic (CB and PV) Ca2+-binding protein expression in the bushy cell somata. In
dn/dn mice, on the other hand, developmental expression of Ca2+-binding proteins does
not increase presynaptically or postsynaptically. This result supports the hypothesis by
Oleskevich and Walmsley (2002) that the enhanced synaptic strength they observed at the
endbulb of Held synapse of dn/dn mice when compared with normal mice may be a result
of impaired Ca2+ buffering in the endbulb terminals in dn/dn mice.
Finally, there are topographic gradients of CR and CB expression in the MNTB
(Fig. 73). In normal mice, these gradients change during development, with expression
of CR (presynaptically) in calyces of Held and CB (postsynaptically) in principal cell
somata increasing progressively in the lateral MNTB. The lateral MNTB is the low
frequency end of the tonotopic map, and preferentially expresses Kv1.1 channels and
their low frequency potassium currents (Leao et al. 2006) (See Fig. 3). Thus, in normal
mice the topographic patterns of CR and CB expression in the MNTB correspond with
the topographic patterns of Kv1.1 channels and low frequency potassium currents, which
underlie part of the tonotopic organization of the MNTB. The lateral part of the MNTB,
it seems, requires an increased level of presynaptic Ca2+ buffering (CR) as development
proceeds in order to ensure the fidelity of low frequency synaptic transmission. In dn/dn
mice, on the other hand, topographic gradients of CR and CB expression in the MNTB do
not change during development. The MNTB in dn/dn mice lacks topographic gradients
of channel and current expression, and lacks a tonotopic organization (Leao et al. 2005,
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2006) (See Fig. 3). Thus, the lack of changes in Ca2+-binding protein expression
gradients in the MNTB of dn/dn mice corresponds with the lack of topographic gradients
of channel and current expression and the overall lack of tonotopic organization in the
MNTB of dn/dn mice. Because CR expression in dn/dn mice does not increase during
development in the lateral MNTB, the fidelity of low frequency transmission cannot be
ensured.
In summary, the results of this experiment demonstrate that patterns of Ca2+binding protein expression in the AVCN and MNTB change during the development of
normal hearing mice in response to evoked auditory nerve activity. It appears that the
developmental changes that occur in expression of these Ca2+-binding proteins are
important for ensuring the fidelity of synaptic transmission in the central auditory
pathway, and that patterns of expression correlate with the established tonotopic
organization of the MNTB in normal mice (Fig. 3). In addition, the results demonstrate
that patterns of Ca2+-binding protein expression are altered in congenitally deaf mice, as
they do not change during development due to the absence of evoked auditory nerve
activity. The altered patterns of Ca2+-binding protein expression in dn/dn mice
correspond with the altered tonotopic organization of the MNTB in dn/dn mice (Fig. 3).
Thus, Ca2+ buffering is impaired at synapses in the central auditory pathways of dn/dn
mice. This is especially important in the AVCN, as it supports the hypothesis by
Oleskevich and Walmsley (2002) that impaired Ca2+ buffering at the endbulb of Held
synapse may be responsible for the enhanced synaptic strength observed at this synapse
in dn/dn mice when compared with normal mice. In order to develop an accurate
quantitative analysis of the developmental expression of these Ca2+-binding proteins in
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the AVCN and MNTB of normal and dn/dn mice, a DAB experiment followed by optical
density analysis is needed. In addition, this experiment will be repeated utilizing
confocal microscopy so that the developmental expression of Ca2+-binding proteins
normal and dn/dn can be examined in greater detail. Confocal microscopy will enable
the results of the current experiment to be verified, and will provide greater insight into
presynaptic changes in PV expression (which were unclear in this experiment) and into
the differences in endbulb of Held morphology observed in the AVCN during the
development of normal hearing and congenitally deaf mice.
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